<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pediatr Radiol</journal-id>
      <journal-title>Pediatric Radiology</journal-title>
      <issn pub-type="ppub">0301-0449</issn>
      <issn pub-type="epub">1432-1998</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18324394</article-id>
      <article-id pub-id-type="pmc">2367394</article-id>
      <article-id pub-id-type="publisher-id">751</article-id>
      <article-id pub-id-type="doi">10.1007/s00247-008-0751-y</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Imaging findings in noncraniofacial childhood rhabdomyosarcoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Van Rijn</surname>
            <given-names>Rick R.</given-names>
          </name>
          <address>
            <email>r.r.vanrijn@amc.uva.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wilde</surname>
            <given-names>Jim C. H.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bras</surname>
            <given-names>Johannes</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Oldenburger</surname>
            <given-names>Foppe</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>McHugh</surname>
            <given-names>Kieran M. C.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Merks</surname>
            <given-names>Johannes H. M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Radiology, Academic Medical Centre Amsterdam, Suite G1-224, Meibergdreef 9, 1105 AZ Amsterdam Zuid-Oost, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Paediatric Surgery, Academic Medical Centre Amsterdam, Amsterdam, The Netherlands </aff>
        <aff id="Aff3"><label>3</label>Department of Pathology, Academic Medical Centre Amsterdam, Amsterdam, The Netherlands </aff>
        <aff id="Aff4"><label>4</label>Department of Radiotherapy, Academic Medical Centre Amsterdam, Amsterdam, The Netherlands </aff>
        <aff id="Aff5"><label>5</label>Department of Paediatric Radiology, Great Ormond Street Hospital for Children, London, UK </aff>
        <aff id="Aff6"><label>6</label>Department of Paediatric Oncology, Academic Medical Centre Amsterdam, Amsterdam, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>3</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2008</year>
      </pub-date>
      <volume>38</volume>
      <issue>6</issue>
      <fpage>617</fpage>
      <lpage>634</lpage>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>9</month>
          <year>2007</year>
        </date>
        <date date-type="rev-recd">
          <day>26</day>
          <month>11</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>1</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2008</copyright-statement>
      </permissions>
      <abstract>
        <p>Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood. This paper is focuses on imaging for diagnosis, staging, and follow-up of noncraniofacial RMS.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Rhabdomyosarcoma</kwd>
        <kwd>Imaging</kwd>
        <kwd>Children</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2008</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Rhabdomyosarcoma (RMS) is the most common paediatric soft-tissue sarcoma and constitutes 3&#x2013;5% of all malignancies in childhood [<xref ref-type="bibr" rid="CR1">1</xref>]. In children, the age-standardized annual incidence rate for RMS is between 4 and 7 per million [<xref ref-type="bibr" rid="CR2">2</xref>]. This review focuses on the imaging of all RMS occurring outside the head and neck region, which comprise 40% of RMS; around 15% are genitourinary (GU) nonbladder prostate tumours (GU-NBP, i.e. paratesticular, vaginal and uterine tumours), 10% are bladder prostate tumours (BP), 15% occur in the limbs, and 20% occur in other sites (i.e. thoracic or abdominal tumours).</p>
      <p>Clinical symptoms vary widely, based on the location of the primary tumour, but in general presenting symptoms often are indolent, with nonspecific or minimal symptoms, at the start mimicking innocent general paediatric diseases. Often the duration or progression of symptoms alerts the physician to the presence of a malignant tumour. Site-specific symptoms in GU-NBP tumours are a paratesticular mass in boys that may be painful or not, while girls may present with a grape-like (botryoid) vaginal extrusion of mucosanguineous tissue or micturition problems. BP tumours may present with urinary retention, haematuria, constipation or an abdominal mass. Limb tumours often present with a painless swelling and/or with enlarged regional lymph nodes, while presentation of tumours in other locations may vary from biliary obstruction in tumours of the biliary tract, to painless masses, all depending on their primary site.</p>
      <p>Patients with metastatic disease present with more general symptoms of fatigue, weight loss, and low blood counts. As soon as a RMS is suspected an extensive work-up must be performed to get a histological diagnosis and correct staging of the tumour. Imaging of the primary site with US, MRI or CT is required in all patients at the start of the diagnostic work-up [<xref ref-type="bibr" rid="CR3">3</xref>]. Once the diagnosis has been confirmed histologically, the most frequently involved metastatic sites will be investigated; CT of the lungs, imaging of regional lymph nodes, and a technetium bone scan are recommended for every patient. Furthermore, bone marrow aspirates and trephines should be performed in all patients, while examination of the cerebral spinal fluid is only required in patients with paraspinal and parameningeal locations. As soon as the work-up has been completed, the patient can be stratified to receive treatment according to the child&#x2019;s risk group, based on the six significant prognostic factors for localized RMS that came out of a retrospective European analysis (European Paediatric Soft-tissue Sarcoma Study Group, EpSSG); histology, postsurgical status according to the Intergroup Rhabdomyosarcoma Study Group (IRSG), tumour site, node involvement, tumour size, and patient age (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>EpSSG prognostic factors [<xref ref-type="bibr" rid="CR28">28</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th>&#xA0;</th><th>Favourable</th><th>Unfavourable</th></tr></thead><tbody><tr><td>Histology</td><td>Embryonal</td><td>Alveolar</td></tr><tr><td>IRSG status</td><td colspan="2">Higher grades more unfavourable</td></tr><tr><td rowspan="3">Tumour site</td><td>Head and neck non-parameningeal</td><td rowspan="3">All other sites</td></tr><tr><td>Orbital</td></tr><tr><td>Genitourinary &#x2013; nonbladder/prostate</td></tr><tr><td>Node involvement</td><td>N0</td><td>N1</td></tr><tr><td>Tumour size (cm)</td><td>&#x2264;5</td><td>&gt;5</td></tr><tr><td>Age (years)</td><td>&lt;10</td><td>&#x2265;10</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec2">
      <title>Pathology</title>
      <p>RMS is a fast-growing, primitive, high-grade, malignant mesenchymal tumour. Depending on their degree of differentiation, the tumour cells manifest features that more or less can be found in the cells of skeletal muscle. These features, essential for the diagnosis, are the presence of myofibrils and cross striations (on light and electron microscopy) and/or positive immunohistochemical staining for markers of muscle differentiation such as desmin and myoD1. For detailed descriptions of the histopathological aspects of RMS, reference should be made to Weiss and Goldblum [<xref ref-type="bibr" rid="CR4">4</xref>] and Fletcher et al. [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>Based on morphology, RMS is traditionally subdivided into embryonal, alveolar and pleomorphic. Pleomorphic RMS, in contrast to embryonal and alveolar RMS, almost exclusively occurs in adults (median age sixth decade), and is therefore not discussed further. Embryonal RMS is the most common type (60&#x2013;70% of all RMS). The cells show a close resemblance to various stages in the embryogenesis of normal skeletal muscle (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Subtypes are botryoid RMS and spindle-cell RMS (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). When arising in the submucosa, embryonal RMS may present as a fast-growing exophytic, polypoid mass. This macroscopic variant is called botryoid RMS (grape-like) and, due to its growth pattern (primary exophytic and not invasive), has a better prognosis.
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Embryonal RMS: small cells and primitive spindle-shaped cells resembling the first stages of developing normal skeletal muscle (H&amp;E, original magnification 10&#xD7;20)</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Embryonal RMS, spindle-cell type: closely packed spindle cells arranged in perpendicular crossing fascicles giving a leiomyosarcoma-like appearance (H&amp;E, original magnification 10&#xD7;20)</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig2_HTML" id="MO2"/></fig></p>
      <p>Spindle-cell RMS comprising about 4% of all RMS, seems to behave less aggressively and is most often encountered in a paratesticular location (about 30% of all paratesticular RMS) and the head and neck [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Histologically spindle cell RMS is characterized by parallel orientation of spindle cells with an eosinophilic, fibrillary cytoplasm and an elongated, hyperchromatic nucleus. The cells are arranged in broad fascicles (fibro-/leiomyosarcoma-like) or in short, interdigitating fascicles (storiform) and whirls with, in contrast to the broad fasciculated variant (leiomyomatous type), an abundant, partly hyalinized collagenous matrix.</p>
      <p>Alveolar RMS is composed of ill-defined, dense aggregates of poorly differentiated round or oval tumour cells that frequently show loss of cohesion (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). This loss of cohesion and the presence of thin fibrous septa result in an alveolar pattern. In cases where the tumour cells do not show loss of cohesion, the term &#x2018;solid alveolar RMS&#x2019; is used. Alveolar RMS represents about 20% of all RMS and has two specific translocations with specific fusion transcripts that can be detected by RT-PCR. The majority (about 55%) show a t(2;13)(q35;q14) translocation with the corresponding fusion transcript PAX3-FKHR [<xref ref-type="bibr" rid="CR8">8</xref>]. In about 22% a t(1;13)(p36;q14) translocation is found with fusion transcript PAX7-FKHR. In rare cases, RMS with a more or less alveolar pattern lacks these translocations.
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Alveolar RMS: cluster of primitive cells with loss of cellular cohesion and bordered by dense fibrous septa, resulting in an alveolar pattern (H&amp;E, original magnification 10&#xD7;20)</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig3_HTML" id="MO3"/></fig></p>
      <p>Both embryonal and alveolar RMS may show rhabdoid tumour-like features and anaplasia (focal or diffuse) [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. More recently, under the heading sclerosing RMS, a variant with hyalin sclerosis has been described (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) [<xref ref-type="bibr" rid="CR11">11</xref>]. It is unclear whether this is a distinct subtype.
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Sclerosing RMS: small cells, primitive spindle-shaped cells and eosinophilic rhabdomyoblasts in a background of hyaline sclerosis (H&amp;E, original magnification 10&#xD7;20)</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig4_HTML" id="MO4"/></fig></p>
      <p>In 1995, the IRSG and the International Society of Paediatric Oncology (SIOP) suggested a prognostically more significant classification (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>) [<xref ref-type="bibr" rid="CR12">12</xref>].
<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>RMS: IRSG and SIOP classification, extended with new variants [<xref ref-type="bibr" rid="CR12">12</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Prognosis</th><th>Subtype</th></tr></thead><tbody><tr><td rowspan="2">I</td><td rowspan="2">Better prognosis</td><td>Embryonal RMS, botryoid type</td></tr><tr><td>Embryonal RMS, spindle-cell type</td></tr><tr><td>II</td><td>Intermediate prognosis</td><td>Embryonal RMS (remaining)</td></tr><tr><td>III</td><td>Worse prognosis</td><td>Alveolar RMS</td></tr><tr><td rowspan="3">IV</td><td rowspan="3">Unclear prognosis</td><td>RMS with rhabdoid features</td></tr><tr><td>Embryonal RMS with diffuse anaplasia</td></tr><tr><td>Sclerosing RMS</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec3">
      <title>Imaging findings</title>
      <sec id="Sec4">
        <title>Radiography</title>
        <p>As RMS is a soft-tissue tumour, conventional radiology plays an insignificant role in its diagnosis. Localized bony erosion adjacent to the primary site is a recognized complication; this area may be hot on a 99mTc-MDP bone scan in the absence of metastatic disease in the skeleton. In contrast to the initial diagnostic work-up, where for the assessment of pulmonary metastases CT is mandatory, AP and lateral chest radiographs are used in the follow-up period.</p>
      </sec>
      <sec id="Sec5">
        <title>Ultrasonography</title>
        <p>US is often the first imaging modality used in children with soft-tissue masses because it is readily available, has high resolution, and can easily assess extent and vascularity of a mass. One should not forget that most soft-tissue lesions are benign, can readily be diagnosed with US, and do not need further diagnostic work-up or even treatment.</p>
        <p>On US, RMS in general shows as a well-defined, slightly hypoechoic inhomogeneous mass that can show significantly increased flow (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). In the particular case of paratesticular RMS, US is the imaging modality of choice, although CT of the abdomen is also necessary to evaluate for retroperitoneal lymphadenopathy. In all other RMS locations additional imaging using CT or MRI is mandatory.
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>A 6-year-old boy with a mass in the left scrotum. US image shows an ill-defined heterogeneous mass surrounding the testis (<italic>open arrow</italic>). The mass shows increased flow (<italic>solid arrow</italic>). Histopathology: embryonal RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig5_HTML" id="MO5"/></fig></p>
        <p>US is also of use in image-guided biopsies. Recently Sebire and Roebuck [<xref ref-type="bibr" rid="CR13">13</xref>] systematically reviewed the pathological diagnosis of paediatric tumours from image-guided needle-core biopsies. They concluded that image-guided biopsy material was sufficient to come to a diagnosis in 94% (95%; CI 92&#x2013;96%) of patients. Complications needing treatment, mostly haemorrhage requiring transfusion, were reported in only 1% of patients. For image-guided biopsies the material obtained should be transported fresh to the pathology department. Fixation should not be performed as this precludes further cytogenetic studies.</p>
      </sec>
      <sec id="Sec6">
        <title>CT</title>
        <p>In order to assess pulmonary metastases from RMS, CT of the chest is a mandatory examination. However, assessment of pulmonary involvement can sometimes be difficult. Although criteria such as number and size of lesions, morphology (noncalcified, round and well-defined) and location (inferior lobes, subpleural spaces, branching vessels) have been applied in adult patients, none has shown 100% specificity. According to the EpSSG guidelines for evaluating chest CT the following criteria with respect to the diagnosis of pulmonary metastases should be applied: one pulmonary or one pleural nodule over 10&#xA0;mm in diameter, two or more well-defined nodules of 5&#x2013;10&#xA0;mm or five or more lesions &gt;5&#xA0;mm [<xref ref-type="bibr" rid="CR3">3</xref>]. This comes with the assumption that there is no other medical explanation for these lesions. When there is a high suspicion that a small lesion is metastatic, and appears to be the only site of metastatic disease, biopsy may be performed. In the EpSSG protocol, lung biopsy is not recommended.</p>
        <p>With the introduction of multidetector CT (MDCT) the advantage of MRI of being a multiplanar imaging modality has been overtaken, and by virtue of its underlying physics, CT is superior to MRI in detecting osseous changes. The drawback of CT in children is the use of ionizing radiation. Since the seminal papers of Paterson et al. [<xref ref-type="bibr" rid="CR14">14</xref>] and Brenner et al. [<xref ref-type="bibr" rid="CR15">15</xref>], we should be aware of the theoretical risk of CT-induced cancer fatalities and take this into consideration especially in the work-up of children with cancer, as they have already proven their tendency to present with a malignancy early in life [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p>
      </sec>
      <sec id="Sec7">
        <title>MRI</title>
        <p>With its superior ability to depict soft-tissue changes, MRI is the primary imaging modality in RMS [<xref ref-type="bibr" rid="CR16">16</xref>]. Although imaging protocols should be tailored for each individual patient, they should at least consist of axial T1-W and T2-W images (for anatomic detail and assessment of neurovascular structures), T1-W images perpendicular to the axial plane, and imaging after gadolinium administration. It is important that at least two series should be identical, one before and one after contrast agent administration, to be able to discern enhancement. Contrast-enhanced series are mandatory and ideally be performed with fat saturation.</p>
        <p>The imaging characteristics of RMS are relatively nonspecific. Like most soft-tissue tumours they have intermediate signal intensity on T1-W images (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>). On T2-W images they tend to be of intermediate-to-high signal intensity. If the tumour contains a high number of septa it may have a lobular shape. RMS in general show strong enhancement on postcontrast imaging (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>). In very rare instances the tumour may show a predominantly cystic appearance (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>). Dynamic series are useful in order to assess tumour vascularity, and to differentiate between postchemotherapy/surgery residual disease and fibrosis.
<fig id="Fig6"><label>Fig.&#xA0;6</label><caption><p>A 13-year-old girl who noticed a small lump near the anus. <bold>a</bold> T1-W MR image shows a well-defined pararectal lesion (<italic>arrow</italic>). <bold>b</bold> After intravenous gadolinium administration the lesion shows homogeneous enhancement (<italic>arrow</italic>) Histopathology: alveolar RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig6_HTML" id="MO6"/></fig><fig id="Fig7"><label>Fig.&#xA0;7</label><caption><p>An 8-year-old girl with haemolysis, fever and a mass underneath the scapula. <bold>a</bold> Coronal STIR image shows a lesion with mixed signal intensity (<italic>open arrow</italic>) and multiple enlarged lymph nodes in the neck (<italic>solid arrow</italic>). <bold>b</bold> Axial T2-W image shows multiple cystic lesions with fluid-fluid levels (<italic>open arrow</italic>). Histopathology: stage IV embryonal RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig7_HTML" id="MO7"/></fig></p>
        <p>For the surgeon, in order to plan surgery, it is of importance to describe the compartment in which the RMS is located [<xref ref-type="bibr" rid="CR17">17</xref>]. Vascular involvement is considered to be absent if there is a normal tissue plane visible between the tumour and the vessel, or if the tumour has a less then a 180&#xB0; circumferential relationship. If the tumour surrounds the vessel for more than 180&#xB0;, it is considered to be encased.</p>
        <p>Two studies have addressed the use of whole-body MRI (WB-MRI) in paediatric oncology [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. In the first study with various malignant tumours WB-MRI had a superior positive predictive value for skeletal metastases compared to bone scintigraphy (94 vs. 76%, respectively), and also a significantly higher sensitivity (99 vs. 26%, respectively) [<xref ref-type="bibr" rid="CR18">18</xref>]. In the second study, WB-MRI had a higher sensitivity (82%) than skeletal scintigraphy (71%) for the detection of bone marrow metastases, but a lower sensitivity than FDG-PET (90%) [<xref ref-type="bibr" rid="CR19">19</xref>]. The authors of both studies concluded that WB-MRI can replace bone scintigraphy. One advantage of this approach would be the implementation of a one-stop-shop approach to childhood RMS. A drawback of MRI in young children is, however, the need for general anaesthesia.</p>
      </sec>
      <sec id="Sec8">
        <title>Bone scintigraphy</title>
        <p>In the current EpSSG protocols, bone scintigraphy is mandatory as part of the work-up in patients with RMS. The finding of an isolated hot spot on the bone scan should be evaluated with conventional radiography or MRI.</p>
        <p>Cogswell et al. [<xref ref-type="bibr" rid="CR20">20</xref>] reported a retrospective series of 40, primarily adult, patients with RMS and found bone metastases in 18%. Bone scintigraphy in their study had a sensitivity of 70% and specificity 95% in the detection of metastatic disease. In contrast to this, in a Dutch study of 109 patients with soft-tissue sarcoma, bone metastases were found in only 8 patients (7%) [<xref ref-type="bibr" rid="CR21">21</xref>]. However, of these eight patients, six reported bone pain and all had other sites of metastatic disease. The authors conclude that the yield of routine bone scintigraphy is low and that it should be reserved for symptomatic or high-risk patients only.</p>
      </sec>
      <sec id="Sec9">
        <title>Positron emission tomography-CT</title>
        <p>In PET-CT studies fluorine-18 fluorodeoxyglucose (<sup>18</sup>F-FDG), a radiolabelled glucose analogue, is used [<xref ref-type="bibr" rid="CR22">22</xref>]. As <sup>18</sup>F-FDG is a glucose analogue, it shows uptake in metabolically active cells, which most malignant tumour cells are. The combination of PET with CT, without moving the relative position of the patient, yields a higher diagnostic accuracy than PET alone (Fig.&#xA0;<xref rid="Fig8" ref-type="fig">8</xref>). In general, the CT scan will be low-dose CT scan only meant to identify anatomical structures. However, as the CT scanners in modern PET-CT systems are of high diagnostic quality, it is also possible to combine a diagnostic CT scan, e.g. for the depiction of pulmonary metastases, with a PET scan.
<fig id="Fig8"><label>Fig.&#xA0;8</label><caption><p>A 19-year-old boy with a history of treated metastatic RMS presented with low back pain. The PET-CT image shows intense <sup>18</sup>F-FDG uptake in the spinal canal (<italic>open arrow</italic>). Physiological excretion of the radiopharmaceutical via the kidneys is visible (<italic>solid arrows</italic>). Histopathology: embryonal RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig8_HTML" id="MO8"/></fig></p>
        <p>The literature on the use of PET-CT in children with RMS is limited to several case reports or small studies [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Although in some cases PET-CT has been shown to be of benefit in individual patients, larger prospective studies are needed.</p>
      </sec>
    </sec>
    <sec id="Sec10">
      <title>Staging and follow-up</title>
      <p>Staging of RMS is of importance for the individual patient as it gives an indication of prognosis, and thus treatment stratification. From a broader perspective staging makes compiling data on larger patient groups for research purposes possible, enabling evaluation of the outcome of different treatment regimens.</p>
      <p>The main staging system is the postsurgical staging system developed by the IRSG. This is currently used by study groups both in the USA and now in Europe also (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>). The IRSG was formed in 1972 and consisted of surgeons, pathologists, oncologists, and radiation oncologists. The absence of radiologists is striking, and paediatric radiologists are still infrequently involved in development of paediatric oncology study protocols, although in the EpSSG RMS 2005, paediatric radiologists were involved in the development of the protocol. For staging regional nodes it is important to be familiar with the regional node stations. Lymph node involvement has a negative impact on prognosis, as has been shown in the SIOP Malignant Mesenchymal Tumor 89 trial [<xref ref-type="bibr" rid="CR25">25</xref>]. Overall 5-year survival was 60% for N1 patients versus 73% in N0 patients (<italic>P</italic>&#x2009;=&#x2009;0.03). Distant lymph node involvement upgrades a patient to stage IV disease (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>), having an adverse impact on prognosis: overall 5-year survival becomes 24% [<xref ref-type="bibr" rid="CR26">26</xref>].
<table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>IRSG classification</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Stage</th><th colspan="2">Characteristics</th></tr></thead><tbody><tr><td rowspan="2">I</td><td rowspan="2">Localized disease completely resected (regional nodes not involved)</td><td>A: Tumour confined to muscle or organ of origin</td></tr><tr><td>B: Tumour infiltrating outside organ of (muscle of) origin</td></tr><tr><td rowspan="3">II</td><td rowspan="3">Localized or regional disease with total resection of gross tumour</td><td>A: Primary tumour grossly resected, with microscopic residual disease (negative findings in local nodes)</td></tr><tr><td>B: Primary tumour and positive nodes completely resected</td></tr><tr><td>C: Primary tumour and positive nodes resected, with evidence of microscopic residual disease</td></tr><tr><td>III</td><td colspan="2">Incomplete resection of tumour or biopsy, with gross residual disease</td></tr><tr><td>IV</td><td colspan="2">Distant metastatic disease present at diagnosis</td></tr></tbody></table></table-wrap></p>
      <p>Table&#xA0;<xref rid="Tab4" ref-type="table">4</xref> lists the regional node stations by primary tumour site. Oval-shape lymph nodes and a short axis &lt;1&#xA0;cm are considered to be normal [<xref ref-type="bibr" rid="CR3">3</xref>]. If the node shows peripheral enhancement or is round with a short axis of 1.5&#x2013;2&#xA0;cm then the node should be considered probably invaded by tumour. Besides surgical resection or needle-core biopsies, lymph node involvement can also be assessed using fine-needle aspiration (FNA). Klijanienko et al. [<xref ref-type="bibr" rid="CR27">27</xref>] reported a review of the use of FNA in 180 tumours; 176 (97.8%) were either diagnosed accurately or as round-cell sarcoma.
<table-wrap id="Tab4"><label>Table&#xA0;4</label><caption><p>Regional node stations by primary tumour site. Disease with involvement of other lymph nodes than those specified in the table should be classified as stage IV</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Anatomical site</th><th>Node station</th></tr></thead><tbody><tr><td rowspan="2">Extremity</td><td>Lower extremity</td><td>Inguinal, femoral, popliteal nodes (rare)</td></tr><tr><td>Upper extremity</td><td>Axillary, brachial, epitrochlear, and infraclavicular nodes</td></tr><tr><td rowspan="3">Genitourinary</td><td>Bladder, prostate, cervix, uterus, paratesticular</td><td>Pelvic, retroperitoneal nodes at renal artery level or below</td></tr><tr><td>Vagina</td><td>Retroperitoneal, pelvic nodes at or below common iliac inguinal nodes</td></tr><tr><td>&#xA0;Vulva</td><td>Inguinal nodes</td></tr><tr><td>Thoracic</td><td>Intrathoracic</td><td>Internal mammary, mediastinal nodes</td></tr><tr><td colspan="2">Retroperitoneum/pelvis</td><td>Pelvic, retroperitoneal nodes</td></tr><tr><td rowspan="2">Trunk</td><td>Abdominal wall</td><td>Inguinal, femoral nodes</td></tr><tr><td>Chest wall</td><td>Axillary, internal mammary, and infraclavicular nodes</td></tr><tr><td rowspan="2">Other</td><td>Biliary</td><td>Liver hilar nodes</td></tr><tr><td>&#xA0;Perianal/perineal</td><td>Inguinal, pelvic nodes (may be bilateral)</td></tr></tbody></table></table-wrap></p>
      <p>Only in patients with intraspinal or suspected meningeal extension (on imaging or clinical assessment) does the EpSSG RMS protocol state that craniospinal MR should also be performed. In the current EpSSG RMS 2005 protocol, risk stratification is based on six criteria that have emerged from the analyses of previous European studies: histology (embryonal vs. alveolar), postsurgical stage (IRSG), tumour site, node stage, tumour size and patient age (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
      <p>During follow-up, tumour size is an important parameter in assessing tumour response. In the current EpSSG protocol complete remission is defined as disappearance of tumour both clinically and on imaging. Minor response is defined as &gt;33% reduction in volume after three courses of chemotherapy; if not reached the patient is eligible for second-line chemotherapy. In recording tumour response the EpSSG uses volumetric evaluation; additionally the presence or absence of a posttherapeutic residue should be mentioned in the radiology report [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
      <p>In studies in adults the use of Response Evaluation Criteria In Solid Tumours (RECIST) has been advocated by the European Organization for Research and Treatment of Cancer (EORTC), National Cancer Institute of Canada Clinical Trials Group and the National Cancer Institute (NCI) of the United States [<xref ref-type="bibr" rid="CR29">29</xref>]. With respect to implementation in children, RECIST have been a matter of debate [<xref ref-type="bibr" rid="CR30">30</xref>]. Recently RECIST were retrospectively applied to ten consecutive children with cancer [<xref ref-type="bibr" rid="CR31">31</xref>]. The authors concluded that tumour size was underestimated and that in disseminated disease many lesions were either calcified or too small to measure and, therefore, that RECIST are not readily applicable in paediatric oncology. Currently the EpSSG has incorporated RECIST to be used alongside the volumetric measurements in their latest protocol in order to prospectively assess the validity of RECIST in a large patient population with a single tumour type.</p>
      <p>Tumour relapse in patients most commonly presents with locoregional disease (51%) compared to distant relapse (41%) [<xref ref-type="bibr" rid="CR32">32</xref>] (Fig.&#xA0;<xref rid="Fig9" ref-type="fig">9</xref>). In a retrospective case-based study the use of PET-CT was advocated; this, however, needs to be evaluated in larger prospective studies [<xref ref-type="bibr" rid="CR33">33</xref>].
<fig id="Fig9"><label>Fig.&#xA0;9</label><caption><p>Two years after initial diagnosis the patient shown in Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref> presented at the outpatient clinic complaining of back pain. <bold>a</bold> Coronal STIR image of the pelvis shows discrete increased signal intensity in the left ischium (<italic>open arrow</italic>). <bold>b</bold> Subsequently acquired PET-CT image confirms the presence of recurrent disease in the same location (<italic>open arrow</italic>). Note excretion of tracer into the urinary bladder (<italic>solid arrow</italic>). <bold>c</bold> PET-CT image also shows a second lesion in the thoracic spine (<italic>open arrow</italic>). Additional rib and pleural metastases were also visible (not visible on this image)</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig9_HTML" id="MO9"/></fig></p>
    </sec>
    <sec id="Sec11">
      <title>Tumour locations</title>
      <sec id="Sec12">
        <title>Genitourinary</title>
        <p>Approximately 25% of all RMS are GU RMS [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. As mentioned above, GU RMS can simply be subdivided into two subgroups based on different prognosis and subsequent treatment strategy, GU bladder/prostate (GU-BP) being an unfavourable location (Fig.&#xA0;<xref rid="Fig10" ref-type="fig">10</xref>). Tumours at other GU non-bladder/prostate (GU-NBP) sites, such as a paratesticular location (testes, epididymis and spermatic cord; Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>), vagina or uterus (Fig.&#xA0;<xref rid="Fig11" ref-type="fig">11</xref>), have a favourable prognosis, and thus require less-intensive treatment [<xref ref-type="bibr" rid="CR36">36</xref>&#x2013;<xref ref-type="bibr" rid="CR48">48</xref>]. There is a caveat to MRI of the bladder in RMS: after intravenous contrast medium administration, layering of contrast medium can occur making it difficult to appreciate bladder wall enhancement [<xref ref-type="bibr" rid="CR49">49</xref>]. T2-W sequences can be particularly useful in this setting to assess bladder wall thickening. Additional cystoscopy is often warranted [<xref ref-type="bibr" rid="CR50">50</xref>]. At the end of treatment, some residual soft-tissue thickening may persist, and on MRI it is impossible to decide whether this is residual scarring or tumour; in these cases endoscopic biopsy is mandatory.
<fig id="Fig10"><label>Fig.&#xA0;10</label><caption><p>A 3-year-old boy with RMS of the prostate. The sagittal T1-W contrast-enhanced MR image shows the lesion invading the bladder wall. A transurethral catheter has been inserted (<italic>open arrow</italic>). Histopathology: botryoid RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig10_HTML" id="MO10"/></fig><fig id="Fig11"><label>Fig.&#xA0;11</label><caption><p>A 2-year-old girl presented with a mass in the vagina. <bold>a</bold> Axial T1-W contrast-enhanced image shows the mass with heterogeneous enhancement. The tumour has both solid (<italic>asterisk</italic>) and fluid (<italic>open arrow</italic>) compartments. <bold>b</bold> Sagittal T2-W MR image shows the mass with mixed signal intensity. The bladder is displaced anteriorly and the uterus cannot be visualized. Histopathology: embryonal RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig11_HTML" id="MO11"/></fig></p>
      </sec>
      <sec id="Sec13">
        <title>Extremities</title>
        <p>RMS of the extremities (Figs.&#xA0;<xref rid="Fig12" ref-type="fig">12</xref> and <xref rid="Fig13" ref-type="fig">13</xref>) is almost always of alveolar histology, tends to occur in older children and young adults, is often present with positive regional lymph nodes, and has a propensity to metastasize to unusual sites; these negative prognostic factors contribute to the relatively poor prognosis of RMS in this location [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. In approximately 12% of patients, nodal involvement is seen on imaging; however, when nodal dissection is performed the rate of nodal involvement increases to almost 50% [<xref ref-type="bibr" rid="CR53">53</xref>]. This discrepancy between imaging findings and nodal dissection might be reduced by using high-quality state-of-the-art US. In current treatment protocols systematic biopsy of regional nodes is advocated, even if the nodes are not palpable or enlarged on imaging; sentinel node procedures are recommended whenever feasible, although the value of upgrading a patient to a higher risk group based merely on a positive sentinel node has not been studied yet. As in all tumours of the extremities, preoperative imaging plays a vital role in the depiction of the relationship between neurovascular bundles and the tumour.
<fig id="Fig12"><label>Fig.&#xA0;12</label><caption><p>A 4-year-old girl presenting with a mass in the left lower leg. <bold>a</bold> Axial T1-W contrast-enhanced MR image shows an ill-defined mass circumferential to the fibula. Note the cortical thinning (<italic>open arrow</italic>) of the fibula. <bold>b</bold> Sagittal PD-weighted image shows diffuse bone marrow metastases. Histopathology: embryonal RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig12_HTML" id="MO12"/></fig><fig id="Fig13"><label>Fig.&#xA0;13</label><caption><p>A 2-month-old boy with a mass in the third ray of the left foot. T1-W MR image shows a discrete lesion (<italic>open arrow</italic>) of intermediate signal intensity. Histopathology: embryonal RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig13_HTML" id="MO13"/></fig></p>
      </sec>
      <sec id="Sec14">
        <title>Other</title>
        <sec id="Sec15">
          <title>Chest wall</title>
          <p>Chest wall RMS (Fig.&#xA0;<xref rid="Fig14" ref-type="fig">14</xref>) is a relatively rare finding with a reported incidence of 3.7% in the IRSG II and IRSG III studies [<xref ref-type="bibr" rid="CR54">54</xref>]. Most of the reports of chest wall involvement are either case reports or small series [<xref ref-type="bibr" rid="CR55">55</xref>&#x2013;<xref ref-type="bibr" rid="CR57">57</xref>]. In a retrospective analysis of 15 patients, Saenz et al. [<xref ref-type="bibr" rid="CR57">57</xref>] found a 5-year survival of 67%.
<fig id="Fig14"><label>Fig.&#xA0;14</label><caption><p>A 4-year-old boy presenting with a mass on the right chest wall. <bold>a</bold> US image shows a heterogeneous mass in the pectoralis major muscle (the pectoralis minor is not involved; <italic>asterisk</italic>). <bold>b</bold> T1-W MR image of the chest shows a mass of intermediate signal intensity. <bold>c</bold> After intravenous contrast medium administration the lesion shows homogeneous enhancement. Histopathology: alveolar RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig14_HTML" id="MO14"/></fig></p>
        </sec>
        <sec id="Sec16">
          <title>Pulmonary</title>
          <p>There is an ongoing debate and controversy whether congenital cystic anomalies predispose children to intralesional development of RMS [<xref ref-type="bibr" rid="CR58">58</xref>&#x2013;<xref ref-type="bibr" rid="CR62">62</xref>]. It has been reported that pleuropulmonary blastoma (PPB) has been mistaken for or classified as RMS arising in congenital cystic adenomatoid malformation (CCAM) on a number of occasions [<xref ref-type="bibr" rid="CR63">63</xref>]. Despite the fact that the exact incidence in CCAM is unknown, it has prompted paediatric surgeons to resect even small pulmonary cystic lesions (Fig.&#xA0;<xref rid="Fig15" ref-type="fig">15</xref>) [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>].
<fig id="Fig15"><label>Fig.&#xA0;15</label><caption><p>A 3-year-old boy with dyspnoea. Chest CT image shows displacement of the trachea (<italic>open arrow</italic>) and oesophagus (<italic>solid arrow</italic>) to the right due to a large mass (<italic>asterisk</italic>) with accompanying pleural effusion. Histopathology: embryonal RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig15_HTML" id="MO15"/></fig></p>
        </sec>
        <sec id="Sec17">
          <title>Biliary tree</title>
          <p>RMS is the most common tumour of the biliary tree in childhood, although it only accounts for approximately 0.04% of all childhood tumours [<xref ref-type="bibr" rid="CR66">66</xref>]. The initial diagnosis will, in most patients, be made on US, which may show a solid or cystic mass situated in the liver hilum, and intrahepatic bile duct dilatation (Fig.&#xA0;<xref rid="Fig16" ref-type="fig">16</xref>). MRI is mandatory for presurgical evaluation, where magnetic resonance cholangiopancreatography (MRCP) can depict the biliary tree (Fig.&#xA0;<xref rid="Fig16" ref-type="fig">16</xref>). In many patients, however, endoscopic retrograde cholangiopancreatography (ERCP) will have to be performed in order to depict intraductal irregularities (Fig.&#xA0;<xref rid="Fig16" ref-type="fig">16</xref>). Biliary tree RMS is a tumour that does not necessarily need to be fully resected in order to achieve long-term survival, as long as adequate radiotherapy is added [<xref ref-type="bibr" rid="CR67">67</xref>]. Intraperitoneal metastases, which can also be found on follow-up, should also be born in mind.
<fig id="Fig16"><label>Fig.&#xA0;16</label><caption><p>An 8-year-old boy presented with abdominal pain and jaundice. <bold>a</bold> US image shows a central process in the liver hilum (<italic>open arrow</italic>) and dilatation of the intrahepatic bile ducts (<italic>solid arrow</italic>). <bold>b</bold> T2-W MR image shows a circumscribed lesion with increased signal intensity (<italic>open arrow</italic>). <bold>c</bold> MRCP image shows intrahepatic bile duct dilatation. Note that the right and left duct systems do not communicate (<italic>open arrow</italic>). <bold>d</bold> ERCP image (ERCP performed in order to insert a stent in the common bile duct). Histopathology: embryonal RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig16_HTML" id="MO16"/></fig></p>
        </sec>
        <sec id="Sec18">
          <title>Other locations</title>
          <p>In extremely rare instances RMS can be found in other organs such as the heart, the diaphragm (Fig.&#xA0;<xref rid="Fig17" ref-type="fig">17</xref>), the omentum, the urachus and the digestive tract [<xref ref-type="bibr" rid="CR68">68</xref>&#x2013;<xref ref-type="bibr" rid="CR76">76</xref>].
<fig id="Fig17"><label>Fig.&#xA0;17</label><caption><p>A 4-year-old boy was shown to have a right-sided pleural effusion on a chest radiograph. Balanced FFE sagittal MR image shows a mass (<italic>open arrow</italic>) arising from the diaphragm (courtesy of S.G.F. Robben, Academic Hospital Maastricht, The Netherlands)</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig17_HTML" id="MO17"/></fig></p>
        </sec>
      </sec>
      <sec id="Sec19">
        <title>Congenital</title>
        <p>RMS has been reported to occur as a congenital tumour (Fig.&#xA0;<xref rid="Fig18" ref-type="fig">18</xref>) [<xref ref-type="bibr" rid="CR77">77</xref>&#x2013;<xref ref-type="bibr" rid="CR81">81</xref>]. In congenital alveolar RMS the prognosis is reported to be extremely poor, despite otherwise adequate treatment [<xref ref-type="bibr" rid="CR79">79</xref>]. Orbach et al. [<xref ref-type="bibr" rid="CR82">82</xref>] reported the SIOP data on soft-tissue sarcoma in the first year of life. In their study population of 16 newborns, with a follow-up of 1.8&#x2013;10.0&#xA0;years, 3 out of 5 newborns with RMS survived. It has been noted that in congenital RMS the disease may be metastatic at the time of birth, with metastases described in a number of organs and in the placenta [<xref ref-type="bibr" rid="CR81">81</xref>].
<fig id="Fig18"><label>Fig.&#xA0;18</label><caption><p>A 4-day-old girl born with a lump on the left foot. Antenatal ultrasonography at 20&#xA0;weeks showed no abnormalities. <bold>a</bold> T1-W MR image shows a large inhomogeneous mass arising from the left foot. <bold>b</bold> Abdominal US image shows popliteal and inguinal nodal invasion, and hepatic and pancreatic metastases (<italic>open arrow</italic>). Due to the poor prognosis, no therapy was given, and the child died several weeks later. Histopathology: poorly differentiated soft-tissue sarcoma without distinct translocations</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig18_HTML" id="MO18"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec20">
      <title>Adult patients</title>
      <p>Every once in a while paediatric radiologists and paediatric oncologists receive a request for help in the management of an adult patient (Fig.&#xA0;<xref rid="Fig19" ref-type="fig">19</xref>). RMS, although seen as a soft-tissue tumour of childhood, can also occur later in life [<xref ref-type="bibr" rid="CR83">83</xref>&#x2013;<xref ref-type="bibr" rid="CR86">86</xref>]. Compared to childhood RMS, adult RMS has a poor outcome. In a large retrospective study of 171 patients 5-year overall survival was only 40% [<xref ref-type="bibr" rid="CR85">85</xref>]. However, the patients in this series treated according to the guidelines for treatment of childhood RMS showed survival figures comparable to those seen in children. This suggests that treatment of adult RMS should be based on paediatric protocols tailored to adults, to increase survival in this age group. In the Academic Medical Centre Amsterdam we have a working group on childhood tumours in (often young) adults that specifically deals with this challenging population. This working group consists of medical oncologists, paediatric oncologists, radiation oncologists, (orthopaedic) surgeons and a paediatric radiologist. Imaging features will in general not be of help, as the pretest likelihood of RMS in an adolescent or adult is extremely low.
<fig id="Fig19"><label>Fig.&#xA0;19</label><caption><p>A 45-year-old man with a mass in the thigh. T1-W contrast-enhanced MR image shows a heterogeneous circumscribed mass in the vastus lateralis muscle of the right leg. Histopathology: alveolar RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig19_HTML" id="MO19"/></fig></p>
    </sec>
    <sec id="Sec21">
      <title>Differential diagnosis</title>
      <p>Given the wide variety of locations in which RMS can be found it is difficult to give a concise list of differential diagnoses. The site of the primary lesion determines the differential diagnosis. Keeping location out of the equation there are, however, certain tumours, such as haemangiomas/vascular malformations (Fig.&#xA0;<xref rid="Fig20" ref-type="fig">20</xref>), adult-type soft-tissue sarcomas, peripheral neuroectodermal tumours (PNET), infantile fibrosarcoma, aggressive fibromatosis, desmoplastic small round-cell tumours and rhabdoid tumours, and other more even rarer soft-tissue tumours such as nonosseous Ewing sarcoma (Fig.&#xA0;<xref rid="Fig21" ref-type="fig">21</xref>), that should be kept in mind when performing US or reading CT or MRI studies of soft-tissue tumours in childhood.
<fig id="Fig20"><label>Fig.&#xA0;20</label><caption><p>A 1-year-old girl with a mass on the left buttock. <bold>a</bold> Duplex US image shows a highly vascularized, well-delineated heterogeneous mass that was initially thought be a haemangioma. <bold>b</bold> Coronal STIR image shows a circumscribed solid lesion that invades the pelvis via the greater sciatic foramen (<italic>open arrow</italic>). <bold>c</bold> After initial resection, with incomplete margins, tumour recurrence was seen. MR image 2.6&#xA0;years after initial diagnosis shows progression of disease extending to the abdominal wall (<italic>open arrow</italic>). Histopathology: alveolar RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig20_HTML" id="MO20"/></fig><fig id="Fig21"><label>Fig.&#xA0;21</label><caption><p>A 22-month-old boy with a mass in the right groin. MRI shows a heterogeneous lesion adjacent to the gracilis muscle (<italic>open arrow</italic>). Histopathology: extraosseous Ewing sarcoma</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig21_HTML" id="MO21"/></fig></p>
    </sec>
    <sec id="Sec22">
      <title>Treatment and prognosis</title>
      <p>Treatment of RMS requires a multidisciplinary approach, where chemotherapy, surgery and radiotherapy (RT) each has its own specific role.</p>
      <sec id="Sec23">
        <title>Chemotherapy</title>
        <p>Before the introduction of chemotherapy only 25% of patients with RMS survived, despite adequate local therapy. This indirectly indicates that the vast majority of patients had at least minimal disseminated disease at diagnosis, whereas, with state-of-the-art imaging techniques and bone marrow investigations, only 15% of patients with RMS present with overt metastatic disease. Besides treating minimal disseminated disease, chemotherapy enables local therapy to be more conservative. In most patients, surgery at diagnosis consists of biopsy only. Chemotherapy is given to all patients; it reduces tumour size and extension and often allows a delay in surgery. The tumour is more likely to be completely resected and mutilating surgery avoided. Most international protocols use vincristine and dactinomycin as standard drugs. The choice of alkylating agent differs between Europe (ifosfamide) and North America (cyclophosphamide). These drugs have proved to be equally effective, but differences in toxicity exist: ifosfamide is more nephrotoxic, whereas cyclophosphamide more gonadotoxic [<xref ref-type="bibr" rid="CR87">87</xref>]. The addition of other antineoplastic agents to vincristine, dactinomycin and alkylators in the treatment of RMS has been investigated, but no significant improvement in outcome has been found [<xref ref-type="bibr" rid="CR88">88</xref>].</p>
      </sec>
      <sec id="Sec24">
        <title>Surgery</title>
        <p>In children surgery often starts during the diagnostic phase with biopsy for histological studies, although here interventional radiology plays an increasing role. Excisional biopsy is not advocated except for paratesticular tumours. Most patients end up with postsurgical stage IRS group III. Surgery is generally delayed until after tumour reduction by chemotherapy. The surgical treatment of RMS is site-specific, but the current paradigm is complete wide excision of the primary tumour with a margin of uninvolved tissue whenever possible. Debulking and mutilating procedures should be avoided.</p>
      </sec>
      <sec id="Sec25">
        <title>Radiotherapy</title>
        <p>The philosophies underlying the treatment strategies in North America and Western Europe have differed in the past. North American protocols involved aggressive surgery and routine RT, except for those tumours that were microscopically radically resected at diagnosis, followed by prolonged chemotherapy regimens for up to 2 years. The SIOP-MMT (International Society for Paediatric Oncology&#x2013;Malignant Mesenchymal Tumour) group advocated the use of chemotherapy and surgery in order to achieve complete remission in as many patients as possible in order to avoid RT in these often very young patients. RT often has devastating effects in growing children, potentially leading to significant cosmetic and functional problems. Radiation tolerance of growing bone is &#x2264;20&#xA0;Gy, but the radiation dose from the treatment of RMS ranges from 36 to 50.4&#xA0;Gy. For certain sites this policy worked out well (e.g. orbital RMS), and in many patients RT could be avoided [<xref ref-type="bibr" rid="CR89">89</xref>]. At most other sites, relapse rates were high, and salvage rates after relapse were low. The treatment protocols in Germany (Co-operative Weichteilsarcom Studie, CWS) and Italy (Italian Cooperative Soft Tissue sarcoma Group, ICG) were between that in North America and that of the SIOP-MMT group. In 2005, the former SIOP-MMT, CWS and ICG joined to form the EpSSG. As a result of extensive cooperation between the European and the North American groups, the similarities in treatment strategies now outnumber the differences [<xref ref-type="bibr" rid="CR90">90</xref>]. Although RT is still deemed essential in many patients to achieve cure, the possibility of radiation-induced second malignant neoplasms must be kept in mind [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>].</p>
      </sec>
      <sec id="Sec26">
        <title>European approach</title>
        <p>Today more than 70% of nonmetastatic RMS are cured, but survivors may suffer from sequelae [<xref ref-type="bibr" rid="CR93">93</xref>&#x2013;<xref ref-type="bibr" rid="CR98">98</xref>]. Therefore, the SIOP-MMT group has tried in their RMS75, MMT84, MMT89 and MMT95 studies to avoid mutilating surgery and RT [<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR100">100</xref>]. Only children &#x2265;3&#xA0;years of age with parameningeal RMS at high risk of meningeal extension and children not achieving complete remission after chemotherapy and surgery were irradiated after intensive chemotherapy. Of all survivors, 49% were treated without significant local therapy [<xref ref-type="bibr" rid="CR93">93</xref>]. Locoregional relapse occurred in 34%. This has lead to an event-free survival (EFS) of 57% and an overall survival (OS) of 71% [<xref ref-type="bibr" rid="CR93">93</xref>]. Alveolar histology was associated with a significantly higher risk of relapse and a much higher risk of metastases.</p>
      </sec>
      <sec id="Sec27">
        <title>North American approach</title>
        <p>In the studies performed by the IRSG the need for RT is based on surgical radicality, localization, and size of the primary tumour. Only completely resected tumours (IRS group I) with a favourable location (stage I; Table&#xA0;<xref rid="Tab5" ref-type="table">5</xref>), and small tumours (&#x2264;5&#xA0;cm) at unfavourable locations (stage II) did not receive RT in the IRS-IV study [<xref ref-type="bibr" rid="CR87">87</xref>]. Grossly resected tumours with microscopic residual disease (IRS group II), and incompletely resected tumours or tumours with gross residual disease after biopsy (IRS group III) were irradiated [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. With this approach in the IRS-IV study an EFS of 78% and an OS of 84% were obtained. Between the IRSG and SIOP-MMT group a significant difference in OS in alveolar RMS was seen (71% vs. 38%) [<xref ref-type="bibr" rid="CR90">90</xref>]. The salvage rate after relapse of an alveolar RMS was low, and therefore in the current European trial, RT is mandatory for all patients with alveolar histology.
<table-wrap id="Tab5"><label>Table&#xA0;5</label><caption><p>Pediatric Oncology Group and Children&#x2019;s Cancer Group for the Study of Rhabdomyosarcoma classification [<xref ref-type="bibr" rid="CR28">28</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Stage</th><th>Site</th><th>Primary tumour<sup>a</sup></th><th>Size<sup>b</sup></th><th>Regional nodes<sup>c</sup></th><th>Distant metastasis<sup>d</sup></th></tr></thead><tbody><tr><td rowspan="3">I</td><td>Orbit</td><td rowspan="3">T1 or T2</td><td rowspan="3">a or b</td><td rowspan="3">N0, N1 or NX</td><td rowspan="3">M0</td></tr><tr><td>Head and neck (excluding parameningeal)</td></tr><tr><td>Genitourinary, nonbladder nonprostate</td></tr><tr><td rowspan="4">II</td><td>Bladder and prostate</td><td rowspan="4">T1 or T2</td><td rowspan="4">a</td><td rowspan="4">N0 or NX</td><td rowspan="4">M0</td></tr><tr><td>Extremity</td></tr><tr><td>Cranial parameningeal</td></tr><tr><td>Other (including trunk, retroperitoneum, etc)</td></tr><tr><td rowspan="4">III</td><td>Bladder and prostate</td><td rowspan="2">T1 or T2</td><td rowspan="2">a</td><td rowspan="2">N1</td><td rowspan="2">M0</td></tr><tr><td>Extremity</td></tr><tr><td>Cranial parameningeal</td><td rowspan="2">T1 or T2</td><td rowspan="2">b</td><td rowspan="2">N0, N1 or NX</td><td rowspan="2">M0</td></tr><tr><td>Other (including trunk, retroperitoneum, etc)</td></tr><tr><td>IV</td><td>All sites</td><td>T1 or T2</td><td>a or b</td><td>N0 or N1</td><td>M1</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup><italic>T1</italic> tumour limited to original muscle or organ, <italic>T2</italic> tumour has extension or fixation to the surrounding tissue.</p><p><sup>b</sup><italic>a</italic> tumour equal to or less then 5&#xA0;cm in greatest dimension, <italic>b</italic> tumour larger than 5&#xA0;cm in greatest dimension.</p><p><sup>c</sup><italic>N0</italic> no clinical involvement of regional nodes, <italic>N1</italic> clinical involvement of regional nodes, <italic>NX</italic> status of regional nodes unknown.</p><p><sup>d</sup><italic>M0</italic> no distant metastasis, <italic>M1</italic> distant metastasis.</p></table-wrap-foot></table-wrap></p>
        <p>As described above, European and American approaches, although historically different, have converged based on the results of successive international trials and extensive cooperation between the European and North American groups [<xref ref-type="bibr" rid="CR90">90</xref>]. As approaches now are very similar, in this review the current EpSSG approach for the different clinical groups is discussed.</p>
      </sec>
      <sec id="Sec28">
        <title>Current EpSSG approach</title>
        <p><bold>IRS group I</bold> In the IRS-I study, a randomized trial in clinical IRS group I patients, no difference was seen in survival between patients treated with chemotherapy and those treated with chemotherapy and RT [<xref ref-type="bibr" rid="CR101">101</xref>]. A subsequent retrospective study based on the subsequent IRS-I to IRS-III trials confirmed that for embryonal RMS although there was a small difference in failure-free survival (FFS) with and without RT, OS was not significantly different [<xref ref-type="bibr" rid="CR103">103</xref>]. On the other hand, for alveolar RMS and undifferentiated RMS, 10-year FFS was 73% vs. 44%, and OS 82% vs. 52% for patients treated with and without RT, respectively [<xref ref-type="bibr" rid="CR103">103</xref>]. Therefore the current EpSSG study recommends RT in non-embryonal RMS only.</p>
        <p><bold>IRS group II</bold> Evaluation of the role of RT in IRS group II patients in subsequent Cooperative Soft Tissue Sarcoma studies (CWS 81, 86, 91 and 96) showed that for embryonal RMS, EFS was significantly different for patients treated with and without RT [<xref ref-type="bibr" rid="CR104">104</xref>]. However, OS at 5&#xA0;years was not significantly different (84% vs. 77%). For patients with tumours of unfavourable histology (independent of site and size), EFS and OS were significantly better when RT was part of the treatment [<xref ref-type="bibr" rid="CR104">104</xref>]. Therefore, in IRS group II patients, RT is recommended. It is compulsory in patients with high-risk features, but may be omitted in patients with favourable histology in whom RT may be considered too toxic when considering patient age and site of the tumour.</p>
        <p><bold>IRS group III</bold> In patients with IRS group III tumours, RT is the only available therapy in patients who cannot receive a secondary complete resection. Patients who do receive a delayed complete resection benefit from additional RT. In the CWS trials 81&#x2013;96 5-year EFS was 77% and 58% for those treated with and without additional RT, respectively [<xref ref-type="bibr" rid="CR28">28</xref>]. OS, however, was not significantly different between the two groups: 84% and 79%, respectively. RT is, therefore, usually indicated except in patients with a favourable site and histology.</p>
      </sec>
    </sec>
    <sec id="Sec29">
      <title>Prognosis</title>
      <p>As malignant tumours in childhood are rare diseases, most children with cancer have been included in international treatment protocols. This way survival for localized disease (85% of patients) has improved from 25% in the early 1970s to 75% in the most recent international trials [<xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR105">105</xref>&#x2013;<xref ref-type="bibr" rid="CR107">107</xref>]. Although results for localized RMS have improved dramatically in the past decades, patients with disseminated disease still have a dismal prognosis, with a 5-year OS of 24% [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
      <p>A way to reduce long-term sequelae of RT may be by using brachytherapy, especially in girls with genital tract RMS and patients with bladder-prostate, extremity, and head and neck RMS [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR108">108</xref>&#x2013;<xref ref-type="bibr" rid="CR111">111</xref>]. Other options are the use of modulated RT (IMRT) and proton therapy [<xref ref-type="bibr" rid="CR112">112</xref>, <xref ref-type="bibr" rid="CR113">113</xref>].</p>
    </sec>
    <sec id="Sec30">
      <title>The postoperative patient</title>
      <p>Image interpretation and management of the patient after surgery and often RT are challenges (Fig.&#xA0;<xref rid="Fig22" ref-type="fig">22</xref>). Most important is proper knowledge of the surgical procedure and/or the radiation field. The following postoperative changes can be encountered in children treated for RMS:
<list list-type="bullet"><list-item><p>Haematoma</p></list-item><list-item><p>Oedema</p></list-item><list-item><p>Soft-tissue infection/abscess</p></list-item><list-item><p>Calcification</p></list-item><list-item><p>Foreign bodies</p></list-item><list-item><p>Muscle flaps/fat pads</p></list-item><list-item><p>Distorted anatomy</p></list-item><list-item><p>Radiation effect</p></list-item></list> Figure&#xA0;<xref rid="Fig23" ref-type="fig">23</xref> shows a possible decision tree to manage postoperative findings on follow-up imaging.
<fig id="Fig22"><label>Fig.&#xA0;22</label><caption><p>A 6-year-old boy with a history of treated bladder RMS. At surgical resection the urethra was damaged leading to a persistent urinoma in, after RT, nonvital tissue. MRI image after treatment shows a mass (<italic>asterisk</italic>) between the urethra (<italic>open arrow</italic>) and the rectum (<italic>solid arrow</italic>). This mass is a vascularized gracilis muscle flap used to repair the defect. Without proper knowledge of the surgical history of the patient, this might have been interpreted as tumour recurrence. Histopathology: embryonal RMS</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig22_HTML" id="MO22"/></fig><fig id="Fig23"><label>Fig.&#xA0;23</label><caption><p>Flow chart for posttreatment lesions found on MRI. <italic>SI</italic> signal intensity, <italic>CE</italic> contrast-enhanced [<xref ref-type="bibr" rid="CR114">114</xref>]</p></caption><graphic position="anchor" xlink:href="247_2008_751_Fig23_HTML" id="MO23"/></fig></p>
    </sec>
    <sec id="Sec31" sec-type="conclusion">
      <title>Conclusion</title>
      <p>In this review we have discussed the findings of RMS outside the craniofacial region. The treatment of RMS requires a multidisciplinary approach, in which paediatric oncologists, radiologists, paediatric surgeons, pathologists and radiation oncologists all play a vital role. Although they are the most common soft-tissue tumour of childhood, these still rare tumours should be evaluated and treated in specialized centres.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Novakovic</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Childhood cancer</article-title>
          <source>Cancer</source>
          <year>1995</year>
          <volume>75</volume>
          <issue>1 Suppl</issue>
          <fpage>395</fpage>
          <lpage>405</lpage>
        </citation>
        <citation citation-type="display-unstructured">Miller RW, Young JL Jr, Novakovic B (1995) Childhood cancer. Cancer 75(1 Suppl):395&#x2013;405 <pub-id pub-id-type="pmid">8001010</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stiller</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Parking</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>International variations in the incidence of childhood soft-tissue sarcomas</article-title>
          <source>Paediatr Perinat Epidemiol</source>
          <year>1994</year>
          <volume>8</volume>
          <fpage>107</fpage>
          <lpage>119</lpage>
        </citation>
        <citation citation-type="display-unstructured">Stiller CA, Parking DM (1994) International variations in the incidence of childhood soft-tissue sarcomas. Paediatr Perinat Epidemiol 8:107&#x2013;119 <pub-id pub-id-type="pmid">8153013</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="other">Brisse H, McHugh K, Scaramuzza D (2005) RMS and non-RMS soft tissue sarcomas. Radiological guidelines. In: EpSSG RMS and NRSTS therapeutic protocols</citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Goldblum</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <source>Enzinger and Weiss&#x2019;s soft tissue tumors</source>
          <year>2001</year>
          <publisher-loc>St. Louis</publisher-loc>
          <publisher-name>Mosby</publisher-name>
          <fpage>785</fpage>
          <lpage>836</lpage>
        </citation>
        <citation citation-type="display-unstructured">Weiss SW, Goldblum JR (2001) Enzinger and Weiss&#x2019;s soft tissue tumors. Mosby, St. Louis, pp 785&#x2013;836 </citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Unni</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <source>WHO classification of tumours: pathology and genetics of tumours of soft tissue and bone</source>
          <year>2002</year>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC Press</publisher-name>
        </citation>
        <citation citation-type="display-unstructured">Fletcher CD, Unni KK, Mertens F (2002) WHO classification of tumours: pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon </citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cavazzana</surname>
              <given-names>AQ</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nifo</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spindle cell rhabdomyosarcoma. A prognostic favourable variant of rhabdomyosarcoma</article-title>
          <source>Am J Surg Pathol</source>
          <year>1992</year>
          <volume>16</volume>
          <fpage>229</fpage>
          <lpage>235</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cavazzana AQ, Schmidt D, Nifo V et al (1992) Spindle cell rhabdomyosarcoma. A prognostic favourable variant of rhabdomyosarcoma. Am J Surg Pathol 16:229&#x2013;235 <pub-id pub-id-type="pmid">1599014</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leuschner</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study</article-title>
          <source>Am J Surg Pathol</source>
          <year>1993</year>
          <volume>17</volume>
          <fpage>221</fpage>
          <lpage>230</lpage>
        </citation>
        <citation citation-type="display-unstructured">Leuschner I, Newton WA Jr, Schmidt D et al (1993) Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region. A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 17:221&#x2013;230 <pub-id pub-id-type="pmid">8434703</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sorensen</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Qualman</surname>
              <given-names>SJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children&#x2019;s oncology group</article-title>
          <source>J Clin Oncol</source>
          <year>2002</year>
          <volume>20</volume>
          <fpage>2672</fpage>
          <lpage>2679</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sorensen PH, Lynch JC, Qualman SJ et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children&#x2019;s oncology group. J Clin Oncol 20:2672&#x2013;2679 <pub-id pub-id-type="pmid">12039929</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kodet</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Hamoudi</surname>
              <given-names>AB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rhabdomyosarcomas with intermediate-filament inclusions and features of rhabdoid tumors. Light microscopic and immunohistochemical study</article-title>
          <source>Am J Surg Pathol</source>
          <year>1991</year>
          <volume>15</volume>
          <fpage>257</fpage>
          <lpage>267</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kodet R, Newton WA Jr, Hamoudi AB et al (1991) Rhabdomyosarcomas with intermediate-filament inclusions and features of rhabdoid tumors. Light microscopic and immunohistochemical study. Am J Surg Pathol 15:257&#x2013;267 <pub-id pub-id-type="pmid">1847608</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kodet</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Hamoudi</surname>
              <given-names>AB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the Intergroup Rhabdomyosarcoma Study</article-title>
          <source>Am J Surg Pathol</source>
          <year>1993</year>
          <volume>17</volume>
          <fpage>443</fpage>
          <lpage>453</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kodet R, Newton WA Jr, Hamoudi AB et al (1993) Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 17:443&#x2013;453 <pub-id pub-id-type="pmid">8470759</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Folpe</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>McKenney</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Bridge</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma</article-title>
          <source>Am J Surg Pathol</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>1175</fpage>
          <lpage>1183</lpage>
        </citation>
        <citation citation-type="display-unstructured">Folpe AL, McKenney JK, Bridge JA et al (2002) Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol 26:1175&#x2013;1183 <pub-id pub-id-type="pmid">12218574</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Newton</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Gehan</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Webber</surname>
              <given-names>BL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification &#x2013; an Intergroup Rhabdomyosarcoma study</article-title>
          <source>Cancer</source>
          <year>1995</year>
          <volume>76</volume>
          <fpage>1073</fpage>
          <lpage>1085</lpage>
        </citation>
        <citation citation-type="display-unstructured">Newton WA Jr, Gehan EA, Webber BL et al (1995) Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification &#x2013; an Intergroup Rhabdomyosarcoma study. Cancer 76:1073&#x2013;1085 <pub-id pub-id-type="pmid">8625211</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sebire</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Roebuck</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Pathological diagnosis of paediatric tumours from image-guided needle core biopsies: a systematic review</article-title>
          <source>Pediatr Radiol</source>
          <year>2006</year>
          <volume>36</volume>
          <fpage>426</fpage>
          <lpage>431</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sebire NJ, Roebuck DJ (2006) Pathological diagnosis of paediatric tumours from image-guided needle core biopsies: a systematic review. Pediatr Radiol 36:426&#x2013;431 <pub-id pub-id-type="pmid">16532346</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paterson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Frush</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Donnelly</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Helical CT of the body: are settings adjusted for pediatric patients?</article-title>
          <source>AJR</source>
          <year>2001</year>
          <volume>176</volume>
          <fpage>297</fpage>
          <lpage>301</lpage>
        </citation>
        <citation citation-type="display-unstructured">Paterson A, Frush DP, Donnelly L (2001) Helical CT of the body: are settings adjusted for pediatric patients? AJR 176:297&#x2013;301 <pub-id pub-id-type="pmid">11159060</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brenner</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Elliston</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>EJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Estimated risks of radiation induced fatal cancer from pediatric CT</article-title>
          <source>AJR</source>
          <year>2001</year>
          <volume>176</volume>
          <fpage>289</fpage>
          <lpage>296</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brenner DJ, Elliston CD, Hall EJ et al (2001) Estimated risks of radiation induced fatal cancer from pediatric CT. AJR 176:289&#x2013;296 <pub-id pub-id-type="pmid">11159059</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Valenzuela</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Imaging and clinical spectrum of rhabdomyosarcoma in children</article-title>
          <source>Clin Imaging</source>
          <year>2000</year>
          <volume>24</volume>
          <fpage>257</fpage>
          <lpage>262</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kim EE, Valenzuela RF, Kumar AJ et al (2000) Imaging and clinical spectrum of rhabdomyosarcoma in children. Clin Imaging 24:257&#x2013;262 <pub-id pub-id-type="pmid">11331151</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Enneking</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Spanier</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Goodman</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The classic &#x2013; a system for the surgical staging of musculoskeletal sarcoma</article-title>
          <source>Clin Orthop Relat Res</source>
          <year>2003</year>
          <volume>415</volume>
          <fpage>4</fpage>
          <lpage>18</lpage>
        </citation>
        <citation citation-type="display-unstructured">Enneking WF, Spanier SS, Goodman MA (2003) The classic &#x2013; a system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 415:4&#x2013;18 <pub-id pub-id-type="pmid">14612624</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goo</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Ghim</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods</article-title>
          <source>Pediatr Radiol</source>
          <year>2005</year>
          <volume>35</volume>
          <fpage>766</fpage>
          <lpage>773</lpage>
        </citation>
        <citation citation-type="display-unstructured">Goo HW, Choi SH, Ghim T et al (2005) Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods. Pediatr Radiol 35:766&#x2013;773 <pub-id pub-id-type="pmid">15864576</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drup-Link</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Franzius</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Link</surname>
              <given-names>TM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET</article-title>
          <source>AJR</source>
          <year>2001</year>
          <volume>177</volume>
          <fpage>229</fpage>
          <lpage>236</lpage>
        </citation>
        <citation citation-type="display-unstructured">Drup-Link HE, Franzius C, Link TM et al (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR 177:229&#x2013;236 <pub-id pub-id-type="pmid">11418435</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cogswell</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Howman-Giles</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bergin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Bone and gallium scintigraphy in children with rhabdomyosarcoma: a 10-year review</article-title>
          <source>Med Pediatr Oncol</source>
          <year>1994</year>
          <volume>22</volume>
          <fpage>15</fpage>
          <lpage>21</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cogswell A, Howman-Giles R, Bergin M (1994) Bone and gallium scintigraphy in children with rhabdomyosarcoma: a 10-year review. Med Pediatr Oncol 22:15&#x2013;21 <pub-id pub-id-type="pmid">8232075</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jager</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Hoekstra</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Leeuw</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Routine bone scintigraphy in primary staging of soft tissue sarcoma; is it worthwhile?</article-title>
          <source>Cancer</source>
          <year>2000</year>
          <volume>89</volume>
          <fpage>1726</fpage>
          <lpage>1731</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jager PL, Hoekstra HJ, Leeuw J et al (2000) Routine bone scintigraphy in primary staging of soft tissue sarcoma; is it worthwhile? Cancer 89:1726&#x2013;1731 <pub-id pub-id-type="pmid">11042567</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jadvar</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Connolly</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Fahey</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
          <article-title>PET and PET/CT in pediatric oncology</article-title>
          <source>Semin Nucl Med</source>
          <year>2007</year>
          <volume>37</volume>
          <fpage>316</fpage>
          <lpage>331</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jadvar H, Connolly LP, Fahey FH (2007) PET and PET/CT in pediatric oncology. Semin Nucl Med 37:316&#x2013;331 <pub-id pub-id-type="pmid">17707239</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ben Arush</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Bar</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Postovsky</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities</article-title>
          <source>J Pediatr Hematol Oncol</source>
          <year>2006</year>
          <volume>28</volume>
          <fpage>440</fpage>
          <lpage>445</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ben Arush MW, Bar SR, Postovsky S et al (2006) Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities. J Pediatr Hematol Oncol 28:440&#x2013;445 <pub-id pub-id-type="pmid">16825990</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCarville</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Christie</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Daw</surname>
              <given-names>NC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PET/CT in the evaluation of childhood sarcomas</article-title>
          <source>AJR</source>
          <year>2005</year>
          <volume>184</volume>
          <fpage>1293</fpage>
          <lpage>1304</lpage>
        </citation>
        <citation citation-type="display-unstructured">McCarville MB, Christie R, Daw NC et al (2005) PET/CT in the evaluation of childhood sarcomas. AJR 184:1293&#x2013;1304 <pub-id pub-id-type="pmid">15788613</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stevens</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Rey</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bouvet</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology &#x2013; SIOP Malignant Mesenchymal Tumor 89</article-title>
          <source>J Clin Oncol</source>
          <year>2005</year>
          <volume>23</volume>
          <fpage>2618</fpage>
          <lpage>2628</lpage>
        </citation>
        <citation citation-type="display-unstructured">Stevens MC, Rey A, Bouvet N et al (2005) Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology &#x2013; SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23:2618&#x2013;2628 <pub-id pub-id-type="pmid">15728225</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Colombatti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Oberlin</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>4787</fpage>
          <lpage>4794</lpage>
        </citation>
        <citation citation-type="display-unstructured">Carli M, Colombatti R, Oberlin O et al (2004) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 22:4787&#x2013;4794 <pub-id pub-id-type="pmid">15570080</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klijanienko</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Caillaud</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Orbach</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyto-histological correlations in primary, recurrent and metastatic rhabdomyosarcoma: the Institut Curie&#x2019;s experience</article-title>
          <source>Diagn Cytopathol</source>
          <year>2007</year>
          <volume>35</volume>
          <fpage>482</fpage>
          <lpage>487</lpage>
        </citation>
        <citation citation-type="display-unstructured">Klijanienko J, Caillaud JM, Orbach D et al (2007) Cyto-histological correlations in primary, recurrent and metastatic rhabdomyosarcoma: the Institut Curie&#x2019;s experience. Diagn Cytopathol 35:482&#x2013;487 <pub-id pub-id-type="pmid">17636492</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="other">Bisogno G, Bergeron C, Jenney M et al (2005) EpSSG RMS 2005; a protocol for non metastatic rhabdomyosarcoma. 1 June 2005, Padova</citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Therasse</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Arbuck</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Eisenhauer</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2000</year>
          <volume>92</volume>
          <fpage>205</fpage>
          <lpage>216</lpage>
        </citation>
        <citation citation-type="display-unstructured">Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205&#x2013;216 <pub-id pub-id-type="pmid">10655437</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McHugh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kao</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Can paediatric radiologists resist RECIST (response evaluation criteria in solid tumours)?</article-title>
          <source>Pediatr Radiol</source>
          <year>2003</year>
          <volume>33</volume>
          <fpage>739</fpage>
          <lpage>743</lpage>
        </citation>
        <citation citation-type="display-unstructured">McHugh K, Kao S (2003) Can paediatric radiologists resist RECIST (response evaluation criteria in solid tumours)? Pediatr Radiol 33:739&#x2013;743 <pub-id pub-id-type="pmid">14655676</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnacle</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>McHugh</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2006</year>
          <volume>46</volume>
          <fpage>127</fpage>
          <lpage>134</lpage>
        </citation>
        <citation citation-type="display-unstructured">Barnacle AM, McHugh K (2006) Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy. Pediatr Blood Cancer 46:127&#x2013;134 <pub-id pub-id-type="pmid">16231313</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pappo</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Crist</surname>
              <given-names>WM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group</article-title>
          <source>J Clin Oncol</source>
          <year>1999</year>
          <volume>17</volume>
          <fpage>3487</fpage>
          <lpage>3493</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pappo AS, Anderson JR, Crist WM et al (1999) Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 17:3487&#x2013;3493 <pub-id pub-id-type="pmid">10550146</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peng</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rabkin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Muzik</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study</article-title>
          <source>Clin Nucl Med</source>
          <year>2006</year>
          <volume>31</volume>
          <fpage>394</fpage>
          <lpage>397</lpage>
        </citation>
        <citation citation-type="display-unstructured">Peng F, Rabkin G, Muzik O (2006) Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study. Clin Nucl Med 31:394&#x2013;397 <pub-id pub-id-type="pmid">16785806</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castellino</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Pediatric genitourinary tumors</article-title>
          <source>Curr Opin Oncol</source>
          <year>2007</year>
          <volume>19</volume>
          <fpage>248</fpage>
          <lpage>253</lpage>
        </citation>
        <citation citation-type="display-unstructured">Castellino SM, McLean TW (2007) Pediatric genitourinary tumors. Curr Opin Oncol 19:248&#x2013;253 <pub-id pub-id-type="pmid">17414644</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agrons</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Lonergan</surname>
              <given-names>GJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>From the archives of the AFIP. Genitourinary rhabdomyosarcoma in children: radiologic-pathologic correlation</article-title>
          <source>Radiographics</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>919</fpage>
          <lpage>937</lpage>
        </citation>
        <citation citation-type="display-unstructured">Agrons GA, Wagner BJ, Lonergan GJ et al (1997) From the archives of the AFIP. Genitourinary rhabdomyosarcoma in children: radiologic-pathologic correlation. Radiographics 17:919&#x2013;937 <pub-id pub-id-type="pmid">9225391</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mak</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>CC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ultrasound diagnosis of paratesticular rhabdomyosarcoma</article-title>
          <source>Br J Radiol</source>
          <year>2004</year>
          <volume>77</volume>
          <fpage>250</fpage>
          <lpage>252</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mak CW, Chou CK, Su CC et al (2004) Ultrasound diagnosis of paratesticular rhabdomyosarcoma. Br J Radiol 77:250&#x2013;252 <pub-id pub-id-type="pmid">15020370</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanghvi</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Purandare</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Jambhekar</surname>
              <given-names>NA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary rhabdomyosarcoma of the seminal vesicle</article-title>
          <source>Br J Radiol</source>
          <year>2004</year>
          <volume>77</volume>
          <fpage>159</fpage>
          <lpage>160</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sanghvi DA, Purandare NC, Jambhekar NA et al (2004) Primary rhabdomyosarcoma of the seminal vesicle. Br J Radiol 77:159&#x2013;160 <pub-id pub-id-type="pmid">15010393</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moroni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nesi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Travaglini</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rhabdomyosarcoma of the spermatic cord. A case report with review of the literature</article-title>
          <source>Urol Int</source>
          <year>2003</year>
          <volume>71</volume>
          <fpage>114</fpage>
          <lpage>117</lpage>
        </citation>
        <citation citation-type="display-unstructured">Moroni M, Nesi G, Travaglini F et al (2003) Rhabdomyosarcoma of the spermatic cord. A case report with review of the literature. Urol Int 71:114&#x2013;117 <pub-id pub-id-type="pmid">12845275</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciftci</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Bingol-Kologlu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Senocak</surname>
              <given-names>ME</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Testicular tumors in children</article-title>
          <source>J Pediatr Surg</source>
          <year>2001</year>
          <volume>36</volume>
          <fpage>1796</fpage>
          <lpage>1801</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ciftci AO, Bingol-Kologlu M, Senocak ME et al (2001) Testicular tumors in children. J Pediatr Surg 36:1796&#x2013;1801 <pub-id pub-id-type="pmid">11733909</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Solomon</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Zurawin</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Vaginoscopic resection for rhabdomyosarcoma of the vagina: a case report and review of the literature</article-title>
          <source>J Pediatr Adolesc Gynecol</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>139</fpage>
          <lpage>142</lpage>
        </citation>
        <citation citation-type="display-unstructured">Solomon LA, Zurawin RK, Edwards CL (2003) Vaginoscopic resection for rhabdomyosarcoma of the vagina: a case report and review of the literature. J Pediatr Adolesc Gynecol 16:139&#x2013;142 <pub-id pub-id-type="pmid">12804937</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martelli</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oberlin</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Rey</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: a report from the Study Committee of the International Society of Pediatric Oncology</article-title>
          <source>J Clin Oncol</source>
          <year>1999</year>
          <volume>17</volume>
          <fpage>2117</fpage>
          <lpage>2122</lpage>
        </citation>
        <citation citation-type="display-unstructured">Martelli H, Oberlin O, Rey A et al (1999) Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: a report from the Study Committee of the International Society of Pediatric Oncology. J Clin Oncol 17:2117&#x2013;2122 <pub-id pub-id-type="pmid">10561266</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arul</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Spicer</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Nonrhabdomyosarcomatous botyroid tumour of the cervix uteri: is it a new entity?</article-title>
          <source>Med Pediatr Oncol</source>
          <year>2000</year>
          <volume>35</volume>
          <fpage>147</fpage>
          <lpage>149</lpage>
        </citation>
        <citation citation-type="display-unstructured">Arul GS, Porter H, Spicer RD (2000) Nonrhabdomyosarcomatous botyroid tumour of the cervix uteri: is it a new entity? Med Pediatr Oncol 35:147&#x2013;149 <pub-id pub-id-type="pmid">10918244</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lowry</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Guido</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>The vulvar mass in the prepubertal child</article-title>
          <source>J Pediatr Adolesc Gynecol</source>
          <year>2000</year>
          <volume>13</volume>
          <fpage>75</fpage>
          <lpage>78</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lowry DL, Guido RS (2000) The vulvar mass in the prepubertal child. J Pediatr Adolesc Gynecol 13:75&#x2013;78 <pub-id pub-id-type="pmid">10869967</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bond</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Seibel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kapur</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rhabdomyosarcoma of the clitoris</article-title>
          <source>Cancer</source>
          <year>1994</year>
          <volume>73</volume>
          <fpage>1984</fpage>
          <lpage>1986</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bond SJ, Seibel N, Kapur S et al (1994) Rhabdomyosarcoma of the clitoris. Cancer 73:1984&#x2013;1986 <pub-id pub-id-type="pmid">8137226</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Primary embryonal rhabdomyosarcoma of the ovary in a 4-year-old girl</article-title>
          <source>Histopathology</source>
          <year>1989</year>
          <volume>15</volume>
          <fpage>309</fpage>
          <lpage>311</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chan YF, Leung CS, Ma L (1989) Primary embryonal rhabdomyosarcoma of the ovary in a 4-year-old girl. Histopathology 15:309&#x2013;311 <pub-id pub-id-type="pmid">2807189</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Montag</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>D&#x2019;ablaing</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schlaerth</surname>
              <given-names>JB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Embryonal rhabdomyosarcoma of the uterine corpus and cervix</article-title>
          <source>Gynecol Oncol</source>
          <year>1986</year>
          <volume>25</volume>
          <fpage>171</fpage>
          <lpage>194</lpage>
        </citation>
        <citation citation-type="display-unstructured">Montag TW, D&#x2019;ablaing G, Schlaerth JB et al (1986) Embryonal rhabdomyosarcoma of the uterine corpus and cervix. Gynecol Oncol 25:171&#x2013;194 <pub-id pub-id-type="pmid">3758828</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hays</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Raney</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Lawrence</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rhabdomyosarcoma of the female urogenital tract</article-title>
          <source>J Pediatr Surg</source>
          <year>1981</year>
          <volume>16</volume>
          <fpage>828</fpage>
          <lpage>834</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hays DM, Raney RB Jr, Lawrence W Jr et al (1981) Rhabdomyosarcoma of the female urogenital tract. J Pediatr Surg 16:828&#x2013;834 <pub-id pub-id-type="pmid">7338762</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghushe</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Drugas</surname>
              <given-names>GT</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyosarcoma of the clitoris</article-title>
          <source>Pediatr Radiol</source>
          <year>2007</year>
          <volume>37</volume>
          <fpage>1179</fpage>
        </citation>
        <citation citation-type="display-unstructured">Ghushe ND, Drugas GT (2007) Rhabdomyosarcoma of the clitoris. Pediatr Radiol 37:1179 <pub-id pub-id-type="pmid">17690877</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McHugh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Boothroyd</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>The role of radiology in childhood rhabdomyosarcoma</article-title>
          <source>Clin Radiol</source>
          <year>1999</year>
          <volume>54</volume>
          <fpage>2</fpage>
          <lpage>10</lpage>
        </citation>
        <citation citation-type="display-unstructured">McHugh K, Boothroyd AE (1999) The role of radiology in childhood rhabdomyosarcoma. Clin Radiol 54:2&#x2013;10 <pub-id pub-id-type="pmid">9915504</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heyn</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Newton</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Raney</surname>
              <given-names>RB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Preservation of the bladder in patients with rhabdomyosarcoma</article-title>
          <source>J Clin Oncol</source>
          <year>1997</year>
          <volume>15</volume>
          <fpage>69</fpage>
          <lpage>75</lpage>
        </citation>
        <citation citation-type="display-unstructured">Heyn R, Newton WA, Raney RB et al (1997) Preservation of the bladder in patients with rhabdomyosarcoma. J Clin Oncol 15:69&#x2013;75 <pub-id pub-id-type="pmid">8996126</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>DV</given-names>
            </name>
            <name>
              <surname>Coffin</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyosarcoma arising in the hand or foot: a clinicopathologic analysis</article-title>
          <source>Pediatr Dev Pathol</source>
          <year>2004</year>
          <volume>7</volume>
          <fpage>361</fpage>
          <lpage>369</lpage>
        </citation>
        <citation citation-type="display-unstructured">Miller DV, Coffin CM, Zhou H (2004) Rhabdomyosarcoma arising in the hand or foot: a clinicopathologic analysis. Pediatr Dev Pathol 7:361&#x2013;369 <pub-id pub-id-type="pmid">15383931</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Rodriguez-Galindo</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Local control in childhood extremity sarcomas: salvaging limbs and sparing function</article-title>
          <source>Med Pediatr Oncol</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>584</fpage>
          <lpage>587</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rao BN, Rodriguez-Galindo C (2003) Local control in childhood extremity sarcomas: salvaging limbs and sparing function. Med Pediatr Oncol 41:584&#x2013;587 <pub-id pub-id-type="pmid">14595726</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breneman</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Wiener</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Issues in the local control of rhabdomyosarcoma</article-title>
          <source>Med Pediatr Oncol</source>
          <year>2000</year>
          <volume>35</volume>
          <fpage>104</fpage>
          <lpage>109</lpage>
        </citation>
        <citation citation-type="display-unstructured">Breneman JC, Wiener ES (2000) Issues in the local control of rhabdomyosarcoma. Med Pediatr Oncol 35:104&#x2013;109 <pub-id pub-id-type="pmid">10918231</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andrassy</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Wiener</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Raney</surname>
              <given-names>RB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thoracic sarcomas in children</article-title>
          <source>Ann Surg</source>
          <year>1998</year>
          <volume>227</volume>
          <fpage>170</fpage>
          <lpage>173</lpage>
        </citation>
        <citation citation-type="display-unstructured">Andrassy RJ, Wiener ES, Raney RB et al (1998) Thoracic sarcomas in children. Ann Surg 227:170&#x2013;173 <pub-id pub-id-type="pmid">9488512</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soyer</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Karnak</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ciftci</surname>
              <given-names>AO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The results of surgical treatment of chest wall tumors in childhood</article-title>
          <source>Pediatr Surg Int</source>
          <year>2006</year>
          <volume>22</volume>
          <fpage>135</fpage>
          <lpage>139</lpage>
        </citation>
        <citation citation-type="display-unstructured">Soyer T, Karnak I, Ciftci AO et al (2006) The results of surgical treatment of chest wall tumors in childhood. Pediatr Surg Int 22:135&#x2013;139 <pub-id pub-id-type="pmid">16328338</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watt</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Chest wall lesions</article-title>
          <source>Paediatr Respir Rev</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>328</fpage>
          <lpage>338</lpage>
        </citation>
        <citation citation-type="display-unstructured">Watt AJ (2002) Chest wall lesions. Paediatr Respir Rev 3:328&#x2013;338 <pub-id pub-id-type="pmid">12457604</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saenz</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Ghavimi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gerald</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chest wall rhabdomyosarcoma</article-title>
          <source>Cancer</source>
          <year>1997</year>
          <volume>80</volume>
          <fpage>1513</fpage>
          <lpage>1517</lpage>
        </citation>
        <citation citation-type="display-unstructured">Saenz NC, Ghavimi F, Gerald W et al (1997) Chest wall rhabdomyosarcoma. Cancer 80:1513&#x2013;1517 <pub-id pub-id-type="pmid">9338477</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doladzas</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arvelakis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Karavokyros</surname>
              <given-names>IG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary rhabdomyosarcoma of the lung arising over cystic pulmonary adenomatoid malformation</article-title>
          <source>Pediatr Hematol Oncol</source>
          <year>2005</year>
          <volume>22</volume>
          <fpage>525</fpage>
          <lpage>529</lpage>
        </citation>
        <citation citation-type="display-unstructured">Doladzas T, Arvelakis A, Karavokyros IG et al (2005) Primary rhabdomyosarcoma of the lung arising over cystic pulmonary adenomatoid malformation. Pediatr Hematol Oncol 22:525&#x2013;529 <pub-id pub-id-type="pmid">16169819</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozcan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Celik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ural</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary pulmonary rhabdomyosarcoma arising within cystic adenomatoid malformation: a case report and review of the literature</article-title>
          <source>J Pediatr Surg</source>
          <year>2001</year>
          <volume>36</volume>
          <fpage>1062</fpage>
          <lpage>1065</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ozcan C, Celik A, Ural Z et al (2001) Primary pulmonary rhabdomyosarcoma arising within cystic adenomatoid malformation: a case report and review of the literature. J Pediatr Surg 36:1062&#x2013;1065 <pub-id pub-id-type="pmid">11431779</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>West</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nicholson</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Colquhoun</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bronchioloalveolar carcinoma in congenital cystic adenomatoid malformation of lung</article-title>
          <source>Ann Thorac Surg</source>
          <year>2007</year>
          <volume>83</volume>
          <fpage>687</fpage>
          <lpage>689</lpage>
        </citation>
        <citation citation-type="display-unstructured">West D, Nicholson AG, Colquhoun I et al (2007) Bronchioloalveolar carcinoma in congenital cystic adenomatoid malformation of lung. Ann Thorac Surg 83:687&#x2013;689 <pub-id pub-id-type="pmid">17258019</pub-id></citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Eng</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Correction: pleuropulmonary blastoma, not rhabdomyosarcoma in a congenital lung cyst</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>370</fpage>
          <lpage>371</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pai S, Eng HL, Lee SY et al (2007) Correction: pleuropulmonary blastoma, not rhabdomyosarcoma in a congenital lung cyst. Pediatr Blood Cancer 48:370&#x2013;371 <pub-id pub-id-type="pmid">16856157</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>d&#x2019;Agostino</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bonoldi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dante</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Embryonal rhabdomyosarcoma of the lung arising in cystic adenomatoid malformation: case report and review of the literature</article-title>
          <source>J Pediatr Surg</source>
          <year>1997</year>
          <volume>32</volume>
          <fpage>1381</fpage>
          <lpage>1383</lpage>
        </citation>
        <citation citation-type="display-unstructured">d&#x2019;Agostino S, Bonoldi E, Dante S et al (1997) Embryonal rhabdomyosarcoma of the lung arising in cystic adenomatoid malformation: case report and review of the literature. J Pediatr Surg 32:1381&#x2013;1383 <pub-id pub-id-type="pmid">9314270</pub-id></citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Priest</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Type I pleuropulmonary blastoma: a report from the international pleuropulmonary blastoma registry</article-title>
          <source>J Clin Oncol</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>4492</fpage>
          <lpage>4498</lpage>
        </citation>
        <citation citation-type="display-unstructured">Priest JR, Hill AD, Williams GM (2006) Type I pleuropulmonary blastoma: a report from the international pleuropulmonary blastoma registry. J Clin Oncol 24:4492&#x2013;4498 <pub-id pub-id-type="pmid">16983119</pub-id></citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Granata</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gambini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Balducci</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bronchioloalveolar carcinoma arising in congenital cystic adenomatoid malformation in a child: a case report and review on malignancies originating in congenital cystic adenomatoid malformation</article-title>
          <source>Pediatr Pulmonol</source>
          <year>1998</year>
          <volume>25</volume>
          <fpage>62</fpage>
          <lpage>66</lpage>
        </citation>
        <citation citation-type="display-unstructured">Granata C, Gambini C, Balducci T et al (1998) Bronchioloalveolar carcinoma arising in congenital cystic adenomatoid malformation in a child: a case report and review on malignancies originating in congenital cystic adenomatoid malformation. Pediatr Pulmonol 25:62&#x2013;66 <pub-id pub-id-type="pmid">9475333</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sauvat</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Michel</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Benachi</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Management of asymptomatic neonatal cystic adenomatoid malformations</article-title>
          <source>J Pediatr Surg</source>
          <year>2003</year>
          <volume>38</volume>
          <fpage>548</fpage>
          <lpage>552</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sauvat F, Michel JL, Benachi A et al (2003) Management of asymptomatic neonatal cystic adenomatoid malformations. J Pediatr Surg 38:548&#x2013;552 <pub-id pub-id-type="pmid">12677563</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roebuck</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>WW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatobiliary rhabdomyosarcoma in children: diagnostic radiology</article-title>
          <source>Pediatr Radiol</source>
          <year>1998</year>
          <volume>28</volume>
          <fpage>101</fpage>
          <lpage>108</lpage>
        </citation>
        <citation citation-type="display-unstructured">Roebuck DJ, Yang WT, Lam WW et al (1998) Hepatobiliary rhabdomyosarcoma in children: diagnostic radiology. Pediatr Radiol 28:101&#x2013;108 <pub-id pub-id-type="pmid">9472056</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spunt</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Lobe</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Pappo</surname>
              <given-names>AS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma</article-title>
          <source>J Pediatr Surg</source>
          <year>2000</year>
          <volume>35</volume>
          <fpage>309</fpage>
          <lpage>316</lpage>
        </citation>
        <citation citation-type="display-unstructured">Spunt SL, Lobe TE, Pappo AS et al (2000) Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg 35:309&#x2013;316 <pub-id pub-id-type="pmid">10693686</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hill</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Dehner</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Gow</surname>
              <given-names>KW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Perianal rhabdomyosarcoma presenting as a perirectal abscess: a report of 11 cases</article-title>
          <source>J Pediatr Surg</source>
          <year>2002</year>
          <volume>37</volume>
          <fpage>576</fpage>
          <lpage>581</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hill DA, Dehner LP, Gow KW et al (2002) Perianal rhabdomyosarcoma presenting as a perirectal abscess: a report of 11 cases. J Pediatr Surg 37:576&#x2013;581 <pub-id pub-id-type="pmid">11912514</pub-id></citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caty</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Oldham</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Prochownik</surname>
              <given-names>EV</given-names>
            </name>
          </person-group>
          <article-title>Embryonal rhabdomyosarcoma of the ampulla of Vater with long-term survival following pancreaticoduodenectomy</article-title>
          <source>J Pediatr Surg</source>
          <year>1990</year>
          <volume>25</volume>
          <fpage>1256</fpage>
          <lpage>1258</lpage>
        </citation>
        <citation citation-type="display-unstructured">Caty MG, Oldham KT, Prochownik EV (1990) Embryonal rhabdomyosarcoma of the ampulla of Vater with long-term survival following pancreaticoduodenectomy. J Pediatr Surg 25:1256&#x2013;1258 <pub-id pub-id-type="pmid">2286899</pub-id></citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Fordham</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intraperitoneal rhabdomyosarcoma in children: incidence and imaging characteristics on CT</article-title>
          <source>AJR</source>
          <year>1998</year>
          <volume>170</volume>
          <fpage>1385</fpage>
          <lpage>1387</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chung CJ, Fordham L, Little S et al (1998) Intraperitoneal rhabdomyosarcoma in children: incidence and imaging characteristics on CT. AJR 170:1385&#x2013;1387 <pub-id pub-id-type="pmid">9574621</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Odim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Reehal</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Laks</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Surgical pathology of cardiac tumors. Two decades at an urban institution</article-title>
          <source>Cardiovasc Pathol</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>267</fpage>
          <lpage>270</lpage>
        </citation>
        <citation citation-type="display-unstructured">Odim J, Reehal V, Laks H et al (2003) Surgical pathology of cardiac tumors. Two decades at an urban institution. Cardiovasc Pathol 12:267&#x2013;270 <pub-id pub-id-type="pmid">14507576</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aksoylar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kansoy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bakiler</surname>
              <given-names>AR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary cardiac rhabdomyosarcoma</article-title>
          <source>Med Pediatr Oncol</source>
          <year>2002</year>
          <volume>38</volume>
          <fpage>146</fpage>
        </citation>
        <citation citation-type="display-unstructured">Aksoylar S, Kansoy S, Bakiler AR et al (2002) Primary cardiac rhabdomyosarcoma. Med Pediatr Oncol 38:146 <pub-id pub-id-type="pmid">11813191</pub-id></citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raney</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Andrassy</surname>
              <given-names>RJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Soft-tissue sarcomas of the diaphragm: a report from the Intergroup Rhabdomyosarcoma Study Group from 1972 to 1997</article-title>
          <source>J Pediatr Hematol Oncol</source>
          <year>2000</year>
          <volume>22</volume>
          <fpage>510</fpage>
          <lpage>514</lpage>
        </citation>
        <citation citation-type="display-unstructured">Raney RB, Anderson JR, Andrassy RJ et al (2000) Soft-tissue sarcomas of the diaphragm: a report from the Intergroup Rhabdomyosarcoma Study Group from 1972 to 1997. J Pediatr Hematol Oncol 22:510&#x2013;514 <pub-id pub-id-type="pmid">11132218</pub-id></citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Mitra</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Berry</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Primary embryonal rhabdomyosarcoma of the diaphragm in a child: case report</article-title>
          <source>Pediatr Radiol</source>
          <year>1999</year>
          <volume>29</volume>
          <fpage>823</fpage>
          <lpage>825</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gupta AK, Mitra DK, Berry M (1999) Primary embryonal rhabdomyosarcoma of the diaphragm in a child: case report. Pediatr Radiol 29:823&#x2013;825 <pub-id pub-id-type="pmid">10552061</pub-id></citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Medeiros</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Baptista</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary rhabdomyosarcoma of the diaphragm: case report and literature review</article-title>
          <source>Rev Hosp Clin Fac Med Sao Paulo</source>
          <year>2002</year>
          <volume>57</volume>
          <fpage>67</fpage>
          <lpage>72</lpage>
        </citation>
        <citation citation-type="display-unstructured">Medeiros CW, Kondo W, Baptista I Jr et al (2002) Primary rhabdomyosarcoma of the diaphragm: case report and literature review. Rev Hosp Clin Fac Med Sao Paulo 57:67&#x2013;72 <pub-id pub-id-type="pmid">11981587</pub-id></citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yokoyama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hayashida</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nagahama</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rhabdomyosarcoma of the urachus. A case report</article-title>
          <source>Acta Cytol</source>
          <year>1997</year>
          <volume>41</volume>
          <issue>4 Suppl</issue>
          <fpage>1293</fpage>
          <lpage>1298</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yokoyama S, Hayashida Y, Nagahama J et al (1997) Rhabdomyosarcoma of the urachus. A case report. Acta Cytol 41(4 Suppl):1293&#x2013;1298 <pub-id pub-id-type="pmid">9990261</pub-id></citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brecher</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Reyes-Mugica</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kamino</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital primary cutaneous rhabdomyosarcoma in a neonate</article-title>
          <source>Pediatr Dermatol</source>
          <year>2003</year>
          <volume>20</volume>
          <fpage>335</fpage>
          <lpage>338</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brecher AR, Reyes-Mugica M, Kamino H et al (2003) Congenital primary cutaneous rhabdomyosarcoma in a neonate. Pediatr Dermatol 20:335&#x2013;338 <pub-id pub-id-type="pmid">12869157</pub-id></citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsunaga</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Shanberg</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Rajpoot</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Prenatal ultrasonographic detection of bladder rhabdomyosarcoma</article-title>
          <source>J Urol</source>
          <year>2003</year>
          <volume>169</volume>
          <fpage>1495</fpage>
          <lpage>1496</lpage>
        </citation>
        <citation citation-type="display-unstructured">Matsunaga GS, Shanberg AM, Rajpoot D (2003) Prenatal ultrasonographic detection of bladder rhabdomyosarcoma. J Urol 169:1495&#x2013;1496 <pub-id pub-id-type="pmid">12629400</pub-id></citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grundy</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gaze</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital alveolar rhabdomyosarcoma: clinical and molecular distinction from alveolar rhabdomyosarcoma in older children</article-title>
          <source>Cancer</source>
          <year>2001</year>
          <volume>91</volume>
          <fpage>606</fpage>
          <lpage>612</lpage>
        </citation>
        <citation citation-type="display-unstructured">Grundy R, Anderson J, Gaze M et al (2001) Congenital alveolar rhabdomyosarcoma: clinical and molecular distinction from alveolar rhabdomyosarcoma in older children. Cancer 91:606&#x2013;612 <pub-id pub-id-type="pmid">11169945</pub-id></citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahmed</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Hussain</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>DJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital rhabdomyosarcoma</article-title>
          <source>Br J Plast Surg</source>
          <year>1999</year>
          <volume>52</volume>
          <fpage>304</fpage>
          <lpage>307</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ahmed OA, Hussain A, King DJ et al (1999) Congenital rhabdomyosarcoma. Br J Plast Surg 52:304&#x2013;307 <pub-id pub-id-type="pmid">10624299</pub-id></citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>FV</given-names>
            </name>
            <name>
              <surname>Dehner</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Belchis</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital disseminated malignant rhabdoid tumor: a distinct clinicopathologic entity demonstrating abnormalities of chromosome 22q11</article-title>
          <source>Am J Surg Pathol</source>
          <year>1999</year>
          <volume>23</volume>
          <fpage>249</fpage>
          <lpage>256</lpage>
        </citation>
        <citation citation-type="display-unstructured">White FV, Dehner LP, Belchis DA et al (1999) Congenital disseminated malignant rhabdoid tumor: a distinct clinicopathologic entity demonstrating abnormalities of chromosome 22q11. Am J Surg Pathol 23:249&#x2013;256 <pub-id pub-id-type="pmid">10078913</pub-id></citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orbach</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rey</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oberlin</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee</article-title>
          <source>J Clin Oncol</source>
          <year>2005</year>
          <volume>23</volume>
          <fpage>4363</fpage>
          <lpage>4371</lpage>
        </citation>
        <citation citation-type="display-unstructured">Orbach D, Rey A, Oberlin O et al (2005) Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. J Clin Oncol 23:4363&#x2013;4371 <pub-id pub-id-type="pmid">15994146</pub-id></citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hulse</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Raja</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rhabdomyosarcoma of the extremities in adults</article-title>
          <source>Acta Orthop Belg</source>
          <year>2006</year>
          <volume>72</volume>
          <fpage>199</fpage>
          <lpage>203</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hulse N, Raja S, Kumar A et al (2006) Rhabdomyosarcoma of the extremities in adults. Acta Orthop Belg 72:199&#x2013;203 <pub-id pub-id-type="pmid">16768266</pub-id></citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parham</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Ellison</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyosarcomas in adults and children: an update</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2006</year>
          <volume>130</volume>
          <fpage>1454</fpage>
          <lpage>1465</lpage>
        </citation>
        <citation citation-type="display-unstructured">Parham DM, Ellison DA (2006) Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med 130:1454&#x2013;1465 <pub-id pub-id-type="pmid">17090187</pub-id></citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrari</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dileo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Casanova</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution</article-title>
          <source>Cancer</source>
          <year>2003</year>
          <volume>98</volume>
          <fpage>571</fpage>
          <lpage>580</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ferrari A, Dileo P, Casanova M et al (2003) Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98:571&#x2013;580 <pub-id pub-id-type="pmid">12879475</pub-id></citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allen</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Moskovic</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adult rhabdomyosarcoma: cross-sectional imaging findings including histopathologic correlation</article-title>
          <source>AJR</source>
          <year>2007</year>
          <volume>189</volume>
          <fpage>371</fpage>
          <lpage>377</lpage>
        </citation>
        <citation citation-type="display-unstructured">Allen SD, Moskovic EC, Fisher C et al (2007) Adult rhabdomyosarcoma: cross-sectional imaging findings including histopathologic correlation. AJR 189:371&#x2013;377 <pub-id pub-id-type="pmid">17646463</pub-id></citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crist</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Meza</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease</article-title>
          <source>J Clin Oncol</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>3091</fpage>
          <lpage>3102</lpage>
        </citation>
        <citation citation-type="display-unstructured">Crist WM, Anderson JR, Meza JL et al (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19:3091&#x2013;3102 <pub-id pub-id-type="pmid">11408506</pub-id></citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crist</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Gehan</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Ragab</surname>
              <given-names>AH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Third Intergroup Rhabdomyosarcoma Study</article-title>
          <source>J Clin Oncol</source>
          <year>1995</year>
          <volume>13</volume>
          <fpage>610</fpage>
          <lpage>630</lpage>
        </citation>
        <citation citation-type="display-unstructured">Crist W, Gehan EA, Ragab AH et al (1995) The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13:610&#x2013;630 <pub-id pub-id-type="pmid">7884423</pub-id></citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oberlin</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Rey</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment &#x2013; results of an international workshop</article-title>
          <source>J Clin Oncol</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>197</fpage>
          <lpage>204</lpage>
        </citation>
        <citation citation-type="display-unstructured">Oberlin O, Rey A, Anderson J et al (2001) Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment &#x2013; results of an international workshop. J Clin Oncol 19:197&#x2013;204 <pub-id pub-id-type="pmid">11134213</pub-id></citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donaldson</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyosarcoma: many similarities, a few philosophical differences</article-title>
          <source>J Clin Oncol</source>
          <year>2005</year>
          <volume>23</volume>
          <fpage>2586</fpage>
          <lpage>2587</lpage>
        </citation>
        <citation citation-type="display-unstructured">Donaldson SS, Anderson JR (2005) Rhabdomyosarcoma: many similarities, a few philosophical differences. J Clin Oncol 23:2586&#x2013;2587 <pub-id pub-id-type="pmid">15728222</pub-id></citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scaradavou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heller</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sklar</surname>
              <given-names>CA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma</article-title>
          <source>Cancer</source>
          <year>1995</year>
          <volume>76</volume>
          <fpage>1860</fpage>
          <lpage>1867</lpage>
        </citation>
        <citation citation-type="display-unstructured">Scaradavou A, Heller G, Sklar CA et al (1995) Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma. Cancer 76:1860&#x2013;1867 <pub-id pub-id-type="pmid">8625059</pub-id></citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalapurakal</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Pediatric radiotherapy. An overview</article-title>
          <source>Radiol Clin North Am</source>
          <year>1997</year>
          <volume>35</volume>
          <fpage>1265</fpage>
          <lpage>1280</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kalapurakal JA, Thomas PR (1997) Pediatric radiotherapy. An overview. Radiol Clin North Am 35:1265&#x2013;1280 <pub-id pub-id-type="pmid">9374990</pub-id></citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stevens</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Treatment for childhood rhabdomyosarcoma: the cost of cure</article-title>
          <source>Lancet Oncol</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>77</fpage>
          <lpage>84</lpage>
        </citation>
        <citation citation-type="display-unstructured">Stevens MC (2005) Treatment for childhood rhabdomyosarcoma: the cost of cure. Lancet Oncol 6:77&#x2013;84 <pub-id pub-id-type="pmid">15683816</pub-id></citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paulino</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Late effects of radiotherapy for pediatric extremity sarcomas</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2004</year>
          <volume>60</volume>
          <fpage>265</fpage>
          <lpage>274</lpage>
        </citation>
        <citation citation-type="display-unstructured">Paulino AC (2004) Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys 60:265&#x2013;274 <pub-id pub-id-type="pmid">15337565</pub-id></citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spunt</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Sweeney</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Hudxon</surname>
              <given-names>MM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors</article-title>
          <source>J Clin Oncol</source>
          <year>2005</year>
          <volume>23</volume>
          <fpage>7143</fpage>
          <lpage>7151</lpage>
        </citation>
        <citation citation-type="display-unstructured">Spunt SL, Sweeney TA, Hudxon MM et al (2005) Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. J Clin Oncol 23:7143&#x2013;7151 <pub-id pub-id-type="pmid">16192598</pub-id></citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geenen</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Cardous-Ubbink</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Kremer</surname>
              <given-names>LC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Medical assessment of adverse health outcomes in long-term survivors of childhood cancer</article-title>
          <source>JAMA</source>
          <year>2007</year>
          <volume>297</volume>
          <fpage>2705</fpage>
          <lpage>2715</lpage>
        </citation>
        <citation citation-type="display-unstructured">Geenen MM, Cardous-Ubbink MC, Kremer LC et al (2007) Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297:2705&#x2013;2715 <pub-id pub-id-type="pmid">17595271</pub-id></citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raney</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jenney</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region: a report from the international workshop</article-title>
          <source>J Urol</source>
          <year>2006</year>
          <volume>176</volume>
          <fpage>2190</fpage>
          <lpage>2194</lpage>
        </citation>
        <citation citation-type="display-unstructured">Raney B, Anderson J, Jenney M et al (2006) Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region: a report from the international workshop. J Urol 176:2190&#x2013;2194 <pub-id pub-id-type="pmid">17070290</pub-id></citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pritchard-Jones</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genes, chromosomes, and rhabdomyosarcoma</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>1999</year>
          <volume>26</volume>
          <fpage>275</fpage>
          <lpage>285</lpage>
        </citation>
        <citation citation-type="display-unstructured">Anderson J, Gordon A, Pritchard-Jones K et al (1999) Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer 26:275&#x2013;285 <pub-id pub-id-type="pmid">10534762</pub-id></citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flamant</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rodary</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Voute</surname>
              <given-names>PA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results</article-title>
          <source>Radiother Oncol</source>
          <year>1985</year>
          <volume>3</volume>
          <fpage>227</fpage>
          <lpage>236</lpage>
        </citation>
        <citation citation-type="display-unstructured">Flamant F, Rodary C, Voute PA et al (1985) Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results. Radiother Oncol 3:227&#x2013;236 <pub-id pub-id-type="pmid">3890032</pub-id></citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flamant</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gerbaulet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nihoul-Fekete</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children</article-title>
          <source>J Clin Oncol</source>
          <year>1990</year>
          <volume>8</volume>
          <fpage>1847</fpage>
          <lpage>1853</lpage>
        </citation>
        <citation citation-type="display-unstructured">Flamant F, Gerbaulet A, Nihoul-Fekete C et al (1990) Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. J Clin Oncol 8:1847&#x2013;1853 <pub-id pub-id-type="pmid">2230871</pub-id></citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maurer</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Crist</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Lawrence</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The intergroup rhabdomyosarcoma study-I. A final report</article-title>
          <source>Cancer</source>
          <year>1988</year>
          <volume>61</volume>
          <fpage>209</fpage>
          <lpage>220</lpage>
        </citation>
        <citation citation-type="display-unstructured">Maurer HM, Crist W, Lawrence W et al (1988) The intergroup rhabdomyosarcoma study-I. A final report. Cancer 61:209&#x2013;220 <pub-id pub-id-type="pmid">3275486</pub-id></citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maurer</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Gehan</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Beltangady</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Intergroup Rhabdomyosarcoma Study-II</article-title>
          <source>Cancer</source>
          <year>1993</year>
          <volume>71</volume>
          <fpage>1904</fpage>
          <lpage>1922</lpage>
        </citation>
        <citation citation-type="display-unstructured">Maurer HM, Gehan EA, Beltangady M et al (1993) The Intergroup Rhabdomyosarcoma Study-II. Cancer 71:1904&#x2013;1922 <pub-id pub-id-type="pmid">8448756</pub-id></citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolden</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Crist</surname>
              <given-names>WM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III</article-title>
          <source>J Clin Oncol</source>
          <year>1999</year>
          <volume>17</volume>
          <fpage>3468</fpage>
          <lpage>3475</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wolden SL, Anderson JR, Crist WM et al (1999) Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 17:3468&#x2013;3475 <pub-id pub-id-type="pmid">10550144</pub-id></citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuck</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mattke</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>143</fpage>
          <lpage>149</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schuck A, Mattke AC, Schmidt B et al (2004) Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary? J Clin Oncol 22:143&#x2013;149 <pub-id pub-id-type="pmid">14701776</pub-id></citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breneman</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Lyden</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pappo</surname>
              <given-names>AS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma &#x2013; a report from the Intergroup Rhabdomyosarcoma Study IV</article-title>
          <source>J Clin Oncol</source>
          <year>2003</year>
          <volume>21</volume>
          <fpage>78</fpage>
          <lpage>84</lpage>
        </citation>
        <citation citation-type="display-unstructured">Breneman JC, Lyden E, Pappo AS et al (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma &#x2013; a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21:78&#x2013;84 <pub-id pub-id-type="pmid">12506174</pub-id></citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koscielniak</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Harms</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Henze</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86</article-title>
          <source>J Clin Oncol</source>
          <year>1999</year>
          <volume>17</volume>
          <fpage>3706</fpage>
          <lpage>3719</lpage>
        </citation>
        <citation citation-type="display-unstructured">Koscielniak E, Harms D, Henze G et al (1999) Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17:3706&#x2013;3719 <pub-id pub-id-type="pmid">10577842</pub-id></citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Martelli</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oberlin</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology</article-title>
          <source>J Clin Oncol</source>
          <year>2003</year>
          <volume>21</volume>
          <fpage>793</fpage>
          <lpage>798</lpage>
        </citation>
        <citation citation-type="display-unstructured">Stewart RJ, Martelli H, Oberlin O et al (2003) Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology. J Clin Oncol 21:793&#x2013;798 <pub-id pub-id-type="pmid">12610176</pub-id></citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buwalda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schouwenburg</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Blank</surname>
              <given-names>LE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol</article-title>
          <source>Eur J Cancer</source>
          <year>2003</year>
          <volume>39</volume>
          <fpage>1594</fpage>
          <lpage>1602</lpage>
        </citation>
        <citation citation-type="display-unstructured">Buwalda J, Schouwenburg PF, Blank LE et al (2003) A novel local treatment strategy for advanced stage head and neck rhabdomyosarcomas in children: results of the AMORE protocol. Eur J Cancer 39:1594&#x2013;1602 <pub-id pub-id-type="pmid">12855267</pub-id></citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haie-Meder</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Flamant</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Revillon</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of brachytherapy in the therapeutic strategy of vesico-prostatic rhabdomyosarcoma in children</article-title>
          <source>Ann Urol (Paris)</source>
          <year>1994</year>
          <volume>28</volume>
          <fpage>302</fpage>
          <lpage>305</lpage>
        </citation>
        <citation citation-type="display-unstructured">Haie-Meder C, Flamant F, Revillon Y et al (1994) The role of brachytherapy in the therapeutic strategy of vesico-prostatic rhabdomyosarcoma in children. Ann Urol (Paris) 28:302&#x2013;305 <pub-id pub-id-type="pmid">7893115</pub-id></citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Magne</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Haie-Meder</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Brachytherapy for genital-tract rhabdomyosarcomas in girls: technical aspects, reports, and perspectives</article-title>
          <source>Lancet Oncol</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>725</fpage>
          <lpage>729</lpage>
        </citation>
        <citation citation-type="display-unstructured">Magne N, Haie-Meder C (2007) Brachytherapy for genital-tract rhabdomyosarcomas in girls: technical aspects, reports, and perspectives. Lancet Oncol 8:725&#x2013;729 <pub-id pub-id-type="pmid">17679082</pub-id></citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merchant</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Parsh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>PL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brachytherapy for pediatric soft-tissue sarcoma</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2000</year>
          <volume>46</volume>
          <fpage>427</fpage>
          <lpage>432</lpage>
        </citation>
        <citation citation-type="display-unstructured">Merchant TE, Parsh N, del Valle PL et al (2000) Brachytherapy for pediatric soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 46:427&#x2013;432 <pub-id pub-id-type="pmid">10661350</pub-id></citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Timmermann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Schuck</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Niggli</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spot-scanning proton therapy for malignant soft tissue tumors in childhood: first experiences at the Paul Scherrer Institute</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2007</year>
          <volume>67</volume>
          <fpage>497</fpage>
          <lpage>504</lpage>
        </citation>
        <citation citation-type="display-unstructured">Timmermann B, Schuck A, Niggli F et al (2007) Spot-scanning proton therapy for malignant soft tissue tumors in childhood: first experiences at the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys 67:497&#x2013;504 <pub-id pub-id-type="pmid">17084557</pub-id></citation>
      </ref>
      <ref id="CR113">
        <label>113.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolden</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Wexler</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Kraus</surname>
              <given-names>DH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2005</year>
          <volume>61</volume>
          <fpage>1432</fpage>
          <lpage>1438</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wolden SL, Wexler LH, Kraus DH et al (2005) Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 61:1432&#x2013;1438 <pub-id pub-id-type="pmid">15817347</pub-id></citation>
      </ref>
      <ref id="CR114">
        <label>114.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shapeero</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Baere</surname>
              <given-names>BT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations</article-title>
          <source>Radiology</source>
          <year>1994</year>
          <volume>190</volume>
          <fpage>263</fpage>
          <lpage>268</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vanel D, Shapeero LG, De Baere T et al (1994) MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations. Radiology 190:263&#x2013;268 <pub-id pub-id-type="pmid">8259417</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>